Stimulation	O
of	O
interleukin-1	B-protein
alpha	I-protein
and	O
interleukin-1	B-protein
beta	I-protein
production	O
in	O
human	B-cell_type
monocytes	I-cell_type
by	O
protein	O
phosphatase	O
1	O
and	O
2A	O
inhibitors	O
.	O

Protein	B-protein
phosphatases	I-protein
1	I-protein
and	I-protein
2A	I-protein
are	O
important	O
in	O
regulating	O
cellular	O
functions	O
by	O
controlling	O
the	O
phosphorylation	O
state	O
of	O
their	O
substrates	O
.	O

In	O
human	B-cell_type
monocytes	I-cell_type
,	O
the	O
inhibitors	O
of	O
these	O
phosphatases	B-protein
,	O
okadaic	O
acid	O
and	O
calyculin	O
A	O
,	O
were	O
found	O
to	O
increase	O
the	O
mRNA	O
accumulation	O
and	O
cytokine	O
production	O
of	O
interleukin-1	B-protein
beta	I-protein
and	O
interleukin-1	B-protein
alpha	I-protein
.	O

The	O
increased	O
mRNA	B-RNA
accumulation	O
was	O
found	O
to	O
be	O
primarily	O
because	O
of	O
the	O
increase	O
in	O
the	O
transcription	O
rate	O
of	O
the	O
interleukin-1	B-DNA
genes	I-DNA
.	O

Stimulation	O
of	O
interleukin-1	B-DNA
gene	I-DNA
transcription	O
may	O
be	O
caused	O
by	O
the	O
stimulation	O
of	O
transcription	B-protein
factor	I-protein
activities	O
,	O
including	O
those	O
of	O
AP-1	B-protein
,	O
by	O
these	O
protein	B-protein
phosphatase	I-protein
inhibitors	O
.	O

Okadaic	O
acid	O
increased	O
the	O
synthesis	O
of	O
the	O
interleukin-1	B-protein
beta	I-protein
precursor	O
and	O
mature	O
forms	O
and	O
their	O
secretion	O
.	O

This	O
increased	O
processing	O
and	O
secretion	O
correlated	O
with	O
the	O
stimulation	O
of	O
IL-1	B-RNA
beta	I-RNA
convertase	I-RNA
mRNA	I-RNA
accumulation	O
.	O

The	O
stimulation	O
of	O
interleukin-1	B-protein
alpha	I-protein
production	O
by	O
okadaic	O
acid	O
was	O
more	O
modest	O
than	O
that	O
of	O
interleukin-1	B-protein
beta	I-protein
.	O

However	O
,	O
the	O
phosphorylation	O
of	O
the	O
precursor	B-protein
interleukin-1	I-protein
alpha	I-protein
cytokine	I-protein
was	O
increased	O
.	O

These	O
results	O
show	O
that	O
protein	O
phosphatase	O
1	O
and	O
2A	O
inhibitors	O
exert	O
multiple	O
effects	O
on	O
cytokine	O
production	O
in	O
human	B-cell_type
monocytes	I-cell_type
and	O
suggest	O
that	O
these	O
two	O
phosphatases	B-protein
play	O
important	O
roles	O
in	O
regulating	O
interleukin-1	B-protein
production	O
.	O

THE	NULL
JOURNAL	NULL
or	NULL
Brorogicat	NULL
CHEMISTRY	NULL
©	NULL
1993	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

268	NULL
,	NULL
No	NULL
.	NULL

8	NULL
,	NULL
Issue	NULL
of	NULL
March	NULL
15	NULL
,	NULL
pp	NULL
.	NULL

5802-5809	NULL
,	NULL
1993	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Stimulation	NULL
of	NULL
Interleukin-1	NULL
«	NULL
a	NULL
«	NULL
and	NULL
14	NULL
Production	NULL
in	NULL
Human	NULL
Monocytes	NULL
by	NULL
Protein	NULL
Phosphatase	NULL
1	NULL
and	NULL
2A	NULL
Inhibitors*	NULL
Sun-sang	NULL
J	NULL
.	NULL

Sung	NULL
?	NULL

and	NULL
Jay	NULL
A.	NULL
Walters	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
July	NULL
16	NULL
,	NULL
1992	NULL
)	NULL
From	NULL
the	NULL
Departments	NULL
of	NULL
Radiation	NULL
Oncology	NULL
and	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
and	NULL
the	NULL
Massey	NULL
Cancer	NULL
Center	NULL
,	NULL
Medical	NULL
College	NULL
of	NULL
Virginia	NULL
,	NULL
Virginia	NULL
Commonwealth	NULL
University	NULL
,	NULL
Richmond	NULL
,	NULL
Virginia	NULL
23298	NULL
Protein	NULL
phosphatases	NULL
1	NULL
and	NULL
2A	NULL
are	NULL
important	NULL
in	NULL
regulating	NULL
cellular	NULL
functions	NULL
by	NULL
controlling	NULL
the	NULL
phosphorylation	NULL
state	NULL
of	NULL
their	NULL
substrates	NULL
.	NULL

In	NULL
human	NULL
monocytes	NULL
,	NULL
the	NULL
inhibitors	NULL
of	NULL
these	NULL
phosphatases	NULL
,	NULL
okadaic	NULL
acid	NULL
and	NULL
calyculin	NULL
A	NULL
,	NULL
were	NULL
found	NULL
to	NULL
increase	NULL
the	NULL
mRNA	NULL
accumulation	NULL
and	NULL
cytokine	NULL
production	NULL
of	NULL
interleukin-18	NULL
and	NULL
interleukin-1	NULL
«	NULL
.	NULL

The	NULL
increased	NULL
mRNA	NULL
accumulation	NULL
was	NULL
found	NULL
to	NULL
be	NULL
primarily	NULL
because	NULL
of	NULL
the	NULL
increase	NULL
in	NULL
the	NULL
transcription	NULL
rate	NULL
of	NULL
the	NULL
interleukin-1	NULL
genes	NULL
.	NULL

Stimulation	NULL
of	NULL
interleukin-1	NULL
gene	NULL
transcription	NULL
may	NULL
be	NULL
caused	NULL
by	NULL
the	NULL
stimulation	NULL
of	NULL
transcription	NULL
factor	NULL
activities	NULL
,	NULL
including	NULL
those	NULL
of	NULL
AP-1	NULL
,	NULL
by	NULL
these	NULL
protein	NULL
phosphatase	NULL
inhibitors	NULL
.	NULL

Okadaic	NULL
acid	NULL
increased	NULL
the	NULL
synthesis	NULL
of	NULL
the	NULL
interleukin-1	NULL
$	NULL
precursor	NULL
and	NULL
mature	NULL
forms	NULL
and	NULL
their	NULL
secretion	NULL
.	NULL

This	NULL
increased	NULL
processing	NULL
and	NULL
secretion	NULL
correlated	NULL
with	NULL
the	NULL
stimulation	NULL
of	NULL
IL-18	NULL
convertase	NULL
mRNA	NULL
accumulation	NULL
.	NULL

The	NULL
stimulation	NULL
of	NULL
interleukin-1l1a	NULL
«	NULL
production	NULL
by	NULL
okadaic	NULL
acid	NULL
was	NULL
more	NULL
modest	NULL
than	NULL
that	NULL
of	NULL
interleukin-	NULL
183	NULL
.	NULL

However	NULL
,	NULL
the	NULL
phosphorylation	NULL
of	NULL
the	NULL
precursor	NULL
interleukin-1a	NULL
cytokine	NULL
was	NULL
increased	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
protein	NULL
phosphatase	NULL
1	NULL
and	NULL
2A	NULL
inhibitors	NULL
exert	NULL
multiple	NULL
effects	NULL
on	NULL
cytokine	NULL
production	NULL
in	NULL
human	NULL
monocytes	NULL
and	NULL
suggest	NULL
that	NULL
these	NULL
two	NULL
phosphatases	NULL
play	NULL
important	NULL
roles	NULL
in	NULL
regulating	NULL
interleukin-1	NULL
production	NULL
.	NULL

Interleukin-1	NULL
(	NULL
IL-1	NULL
)	NULL
is	NULL
an	NULL
important	NULL
cytokine	NULL
in	NULL
inflammation	NULL
and	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
many	NULL
immunological	NULL
and	NULL
physiological	NULL
responses	NULL
such	NULL
as	NULL
endotoxic	NULL
shock	NULL
,	NULL
anorexia	NULL
,	NULL
endothelium	NULL
activation	NULL
,	NULL
and	NULL
increased	NULL
acute-phase	NULL
protein	NULL
production	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Ref	NULL
.	NULL

1	NULL
)	NULL
.	NULL

At	NULL
the	NULL
cellular	NULL
level	NULL
,	NULL
IL-1	NULL
increases	NULL
the	NULL
synthesis	NULL
of	NULL
many	NULL
cytokines	NULL
,	NULL
enzymes	NULL
,	NULL
serum	NULL
proteins	NULL
,	NULL
oncogenes	NULL
,	NULL
and	NULL
adhesion	NULL
molecules	NULL
,	NULL
presumably	NULL
by	NULL
stimulating	NULL
the	NULL
activities	NULL
of	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
AP-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Hematopoietic	NULL
cells	NULL
of	NULL
the	NULL
myelomonocytic	NULL
lineage	NULL
,	NULL
keratinocytes	NULL
,	NULL
and	NULL
many	NULL
other	NULL
cell	NULL
types	NULL
produce	NULL
IL-1	NULL
abundantly	NULL
.	NULL

Of	NULL
the	NULL
two	NULL
forms	NULL
of	NULL
IL-1	NULL
,	NULL
IL-1a	NULL
and	NULL
IL-1	NULL
$	NULL
,	NULL
IL-18	NULL
is	NULL
the	NULL
predominant	NULL
form	NULL
produced	NULL
by	NULL
monocytes	NULL
and	NULL
macrophages	NULL
.	NULL

Both	NULL
forms	NULL
are	NULL
produced	NULL
as	NULL
31-33-kDa	NULL
precursor	NULL
proteins	NULL
that	NULL
are	NULL
processed	NULL
by	NULL
specific	NULL
proteases	NULL
to	NULL
the	NULL
*	NULL
This	NULL
work	NULL
was	NULL
support	NULL
in	NULL
part	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grants	NULL
AI-26928	NULL
(	NULL
to	NULL
S.	NULL
J.	NULL
S.	NULL
)	NULL
and	NULL
P30-CA16059	NULL
(	NULL
to	NULL
the	NULL
Massey	NULL
Cancer	NULL
Center	NULL
at	NULL
the	NULL
Medical	NULL
College	NULL
of	NULL
Virginia	NULL
)	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

+	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Dept	NULL
.	NULL

of	NULL
Radiation	NULL
Oncology	NULL
,	NULL
Medical	NULL
College	NULL
of	NULL
Virginia	NULL
,	NULL
Box	NULL
58	NULL
,	NULL
Richmond	NULL
,	NULL
VA	NULL
23298-0058	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
804-786-8778	NULL
;	NULL
Fax	NULL
:	NULL
804-371-6042	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
IL	NULL
,	NULL
interleukin	NULL
;	NULL
LPS	NULL
,	NULL
lipopolysaccha-ride	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
;	NULL
TNF	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
;	NULL
OA	NULL
,	NULL
okadaic	NULL
acid	NULL
.	NULL

active	NULL
17.5-kDa	NULL
mature	NULL
form	NULL
.	NULL

An	NULL
IL-1	NULL
{	NULL
-specific	NULL
processing	NULL
enzyme	NULL
,	NULL
the	NULL
convertase	NULL
,	NULL
has	NULL
recently	NULL
been	NULL
characterized	NULL
and	NULL
cloned	NULL
(	NULL
2	NULL
,	NULL
3	NULL
)	NULL
.	NULL

The	NULL
secretory	NULL
pathway	NULL
for	NULL
IL-1	NULL
is	NULL
unique	NULL
among	NULL
secreted	NULL
proteins	NULL
in	NULL
that	NULL
IL-1	NULL
is	NULL
produced	NULL
as	NULL
a	NULL
cytosolic	NULL
protein	NULL
,	NULL
processed	NULL
in	NULL
the	NULL
cytosol	NULL
,	NULL
and	NULL
secreted	NULL
without	NULL
transit	NULL
through	NULL
the	NULL
conventional	NULL
rough	NULL
endoplasmic	NULL
reticulum-Golgi	NULL
pathway	NULL
(	NULL
4	NULL
)	NULL
.	NULL

IL-1	NULL
secretion	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
stimulated	NULL
by	NULL
Ca®*-ionophores	NULL
,	NULL
nigericin	NULL
,	NULL
and	NULL
protein	NULL
kinase	NULL
C	NULL
stimulation	NULL
(	NULL
5-7	NULL
)	NULL
.	NULL

The	NULL
precursor	NULL
form	NULL
of	NULL
IL-18	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
its	NULL
mature	NULL
form	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
also	NULL
secreted	NULL
by	NULL
macrophages	NULL
(	NULL
8	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
active	NULL
secretion	NULL
of	NULL
precursor	NULL
and	NULL
mature	NULL
IL-1	NULL
by	NULL
viable	NULL
macrophages	NULL
has	NULL
been	NULL
disputed	NULL
(	NULL
9	NULL
)	NULL
.	NULL

IL-1	NULL
production	NULL
is	NULL
stimulated	NULL
by	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
,	NULL
muramyl	NULL
dipeptides	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
PMA	NULL
)	NULL
,	NULL
and	NULL
cytokines	NULL
such	NULL
as	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
(	NULL
TNF	NULL
)	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
IL-1	NULL
itself	NULL
(	NULL
1	NULL
)	NULL
.	NULL

These	NULL
stimulants	NULL
increase	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
IL-1	NULL
genes	NULL
.	NULL

For	NULL
primary	NULL
monocytes	NULL
,	NULL
LPS	NULL
is	NULL
by	NULL
far	NULL
the	NULL
strongest	NULL
physiological	NULL
stimulant	NULL
.	NULL

Besides	NULL
transcriptional	NULL
regulation	NULL
,	NULL
the	NULL
production	NULL
of	NULL
IL-1	NULL
is	NULL
regulated	NULL
translationally	NULL
by	NULL
cAMP	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
and	NULL
dexamethasone	NULL
(	NULL
12	NULL
)	NULL
.	NULL

The	NULL
regulation	NULL
of	NULL
IL-1	NULL
gene	NULL
by	NULL
transcription	NULL
factors	NULL
is	NULL
poorly	NULL
understood	NULL
.	NULL

Stimulants	NULL
of	NULL
IL-1	NULL
transcription	NULL
such	NULL
as	NULL
LPS	NULL
,	NULL
PMA	NULL
,	NULL
TNF	NULL
,	NULL
and	NULL
IL-1	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
increase	NULL
the	NULL
binding	NULL
activities	NULL
of	NULL
AP-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
13-16	NULL
)	NULL
whose	NULL
binding	NULL
motifs	NULL
are	NULL
present	NULL
in	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
IL-1	NULL
genes	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

PMA	NULL
and	NULL
LPS	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
exert	NULL
their	NULL
activating	NULL
functions	NULL
by	NULL
increasing	NULL
protein	NULL
kinase	NULL
C	NULL
activity	NULL
(	NULL
16	NULL
,	NULL
19	NULL
)	NULL
.	NULL

It	NULL
is	NULL
therefore	NULL
likely	NULL
that	NULL
phosphorylation	NULL
regulation	NULL
is	NULL
important	NULL
in	NULL
IL-1	NULL
gene	NULL
activation	NULL
.	NULL

Besides	NULL
protein	NULL
kinases	NULL
,	NULL
Ser/Thr	NULL
protein	NULL
phosphatases	NULL
have	NULL
recently	NULL
been	NULL
shown	NULL
to	NULL
play	NULL
important	NULL
roles	NULL
in	NULL
regulating	NULL
cellular	NULL
functions	NULL
by	NULL
modulating	NULL
the	NULL
phosphorylation	NULL
state	NULL
of	NULL
critical	NULL
phosphoproteins	NULL
(	NULL
20	NULL
,	NULL
21	NULL
)	NULL
.	NULL

The	NULL
phosphatase	NULL
1	NULL
and	NULL
2A	NULL
inhibitors	NULL
okadaic	NULL
acid	NULL
(	NULL
OA	NULL
)	NULL
and	NULL
calyculin	NULL
A	NULL
are	NULL
capable	NULL
of	NULL
exerting	NULL
multiple	NULL
effects	NULL
on	NULL
cellular	NULL
functions	NULL
,	NULL
including	NULL
changes	NULL
in	NULL
glucose	NULL
and	NULL
fatty	NULL
acid	NULL
metabolism	NULL
and	NULL
cellular	NULL
ion	NULL
balance	NULL
(	NULL
20	NULL
,	NULL
21	NULL
)	NULL
,	NULL
the	NULL
stimulation	NULL
of	NULL
neurotransmitter	NULL
release	NULL
(	NULL
22	NULL
)	NULL
and	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
activity	NULL
(	NULL
23	NULL
)	NULL
,	NULL
and	NULL
the	NULL
activation	NULL
of	NULL
urokinase-type	NULL
plasminogen	NULL
activator	NULL
and	NULL
urokinase	NULL
receptor	NULL
genes	NULL
(	NULL
24	NULL
,	NULL
25	NULL
)	NULL
.	NULL

More	NULL
recently	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
these	NULL
phosphatase	NULL
inhibitors	NULL
induce	NULL
TNF	NULL
production	NULL
in	NULL
human	NULL
monocytes	NULL
(	NULL
26	NULL
)	NULL
.	NULL

The	NULL
stimulation	NULL
of	NULL
gene	NULL
transcription	NULL
by	NULL
OA	NULL
may	NULL
be	NULL
a	NULL
result	NULL
of	NULL
the	NULL
stimulation	NULL
of	NULL
the	NULL
binding	NULL
activities	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
AP-1	NULL
,	NULL
AP-2	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
and	NULL
Egr-1	NULL
(	NULL
26-29	NULL
)	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
have	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
these	NULL
protein	NULL
phosphatase	NULL
inhibitors	NULL
on	NULL
the	NULL
production	NULL
of	NULL
IL-1a	NULL
and	NULL
IL-1	NULL
(	NULL
8	NULL
.	NULL

We	NULL
found	NULL
that	NULL
the	NULL
production	NULL
of	NULL
IL-18	NULL
was	NULL
markedly	NULL
increased	NULL
by	NULL
OA	NULL
,	NULL
and	NULL
the	NULL
increase	NULL
was	NULL
caused	NULL
by	NULL
the	NULL
increased	NULL
transcription	NULL
rate	NULL
of	NULL
the	NULL
IL-18	NULL
gene	NULL
.	NULL

Increased	NULL
IL-1	NULL
processing	NULL
and	NULL
secretion	NULL
may	NULL
also	NULL
be	NULL
because	NULL
of	NULL
the	NULL
stimulation	NULL
of	NULL
the	NULL
activities	NULL
of	NULL
IL-18	NULL
convertase	NULL
whose	NULL
mRNA	NULL
accumulation	NULL
was	NULL
increased	NULL
severalfold	NULL
by	NULL
LPS	NULL
and	NULL
5802	NULL
Okadaic	NULL
Acid	NULL
and	NULL
Calyculin	NULL
A	NULL
Stimulation	NULL
of	NULL
IL-1	NULL
Production	NULL
OA	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
OA	NULL
induced	NULL
more	NULL
modest	NULL
IL-1a	NULL
cytokine	NULL
production	NULL
and	NULL
mRNA	NULL
accumulation	NULL
,	NULL
although	NULL
the	NULL
phosphorylation	NULL
of	NULL
IL-1a	NULL
protein	NULL
was	NULL
increased	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Materials-OA	NULL
and	NULL
calyculin	NULL
A	NULL
were	NULL
from	NULL
Moana	NULL
Bioproducts	NULL
(	NULL
Honolulu	NULL
,	NULL
HI	NULL
)	NULL
.	NULL

The	NULL
properties	NULL
of	NULL
the	NULL
goat	NULL
anti-IL-1a	NULL
and	NULL
IL-18	NULL
antisera	NULL
,	NULL
kind	NULL
gifts	NULL
of	NULL
Dr.	NULL
R.	NULL
Chizzonite	NULL
(	NULL
Roche	NULL
Institute	NULL
of	NULL
Molecular	NULL
Biology	NULL
,	NULL
Nutley	NULL
,	NULL
NJ	NULL
)	NULL
,	NULL
have	NULL
been	NULL
described	NULL
(	NULL
10	NULL
)	NULL
.	NULL

LPS	NULL
(	NULL
Salmonella	NULL
typhosa	NULL
)	NULL
,	NULL
PMA	NULL
,	NULL
actinomycin	NULL
D	NULL
,	NULL
NADH	NULL
,	NULL
pyruvate	NULL
,	NULL
and	NULL
lactate	NULL
dehydrogenase	NULL
were	NULL
purchased	NULL
from	NULL
Sigma	NULL
.	NULL

The	NULL
sources	NULL
of	NULL
most	NULL
of	NULL
the	NULL
cDNA	NULL
probes	NULL
and	NULL
other	NULL
reagents	NULL
have	NULL
been	NULL
described	NULL
(	NULL
10	NULL
,	NULL
26	NULL
,	NULL
30	NULL
)	NULL
.	NULL

The	NULL
rat	NULL
fra-1	NULL
,	NULL
mouse	NULL
fosB	NULL
,	NULL
and	NULL
human	NULL
IL-1	NULL
convertase	NULL
cDNA	NULL
probes	NULL
were	NULL
generously	NULL
provided	NULL
by	NULL
Drs	NULL
.	NULL

T.	NULL
Curran	NULL
(	NULL
Roche	NULL
Institute	NULL
of	NULL
Molecular	NULL
Biology	NULL
)	NULL
,	NULL
R.	NULL
Bravo	NULL
(	NULL
Bristol-Myers	NULL
Squibb	NULL
Pharmaceutical	NULL
Research	NULL
Institute	NULL
,	NULL
Princeton	NULL
,	NULL
NJ	NULL
)	NULL
,	NULL
and	NULL
D.	NULL
P.	NULL
Cerretti	NULL
(	NULL
Immunex	NULL
Research	NULL
and	NULL
Development	NULL
Corp.	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

Cell	NULL
Culture-Cells	NULL
lines	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
(	NULL
GIBCO	NULL
)	NULL
supplemented	NULL
with	NULL
2	NULL
mM	NULL
Gin	NULL
,	NULL
50	NULL
units/ml	NULL
penicillin	NULL
,	NULL
50	NULL
ug/ml	NULL
streptomycin	NULL
sulfate	NULL
,	NULL
and	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
HyClone	NULL
Laboratories	NULL
,	NULL
Logan	NULL
UT	NULL
)	NULL
.	NULL

Human	NULL
monocytes	NULL
were	NULL
isolated	NULL
from	NULL
buffy	NULL
coat	NULL
preparations	NULL
(	NULL
Richmond	NULL
Metropolitan	NULL
Blood	NULL
Service	NULL
,	NULL
Richmond	NULL
VA	NULL
)	NULL
by	NULL
Ficoll-Paque	NULL
centrifugation	NULL
,	NULL
E-rosette	NULL
,	NULL
and	NULL
Percoll	NULL
centrifugation	NULL
essentially	NULL
as	NULL
described	NULL
(	NULL
10	NULL
,	NULL
26	NULL
)	NULL
.	NULL

All	NULL
solutions	NULL
used	NULL
for	NULL
isolating	NULL
and	NULL
culturing	NULL
monocytes	NULL
were	NULL
tested	NULL
by	NULL
the	NULL
limulus	NULL
amoebocyte	NULL
lysate	NULL
assay	NULL
(	NULL
Sigma	NULL
)	NULL
to	NULL
be	NULL
<	NULL
0.002	NULL
ng/ml	NULL
LPS	NULL
contamination	NULL
.	NULL

The	NULL
sources	NULL
of	NULL
these	NULL
reagents	NULL
have	NULL
been	NULL
described	NULL
(	NULL
10	NULL
)	NULL
.	NULL

The	NULL
monocytes	NULL
preparations	NULL
were	NULL
>	NULL
95	NULL
%	NULL
pure	NULL
as	NULL
determined	NULL
by	NULL
the	NULL
nonspecific	NULL
esterase	NULL
staining	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Cell	NULL
viabilities	NULL
were	NULL
determined	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Cultures	NULL
were	NULL
>	NULL
95	NULL
%	NULL
viable	NULL
at	NULL
the	NULL
end	NULL
of	NULL
experiments	NULL
.	NULL

Northern	NULL
Blot	NULL
Analysis-Total	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
cells	NULL
by	NULL
ultracentrifugation	NULL
of	NULL
the	NULL
guanidine	NULL
thiocyanate	NULL
lysate	NULL
over	NULL
a	NULL
CsCl	NULL
cushion	NULL
as	NULL
described	NULL
(	NULL
31	NULL
,	NULL
32	NULL
)	NULL
.	NULL

RNA	NULL
was	NULL
fractionated	NULL
in	NULL
a	NULL
1.4	NULL
%	NULL
formaldehyde	NULL
gel	NULL
,	NULL
transferred	NULL
to	NULL
GeneScreen	NULL
Plus	NULL
membranes	NULL
(	NULL
Du	NULL
Pont-New	NULL
England	NULL
Nuclear	NULL
)	NULL
,	NULL
and	NULL
hybridized	NULL
with	NULL
nick-translated	NULL
probes	NULL
as	NULL
described	NULL
(	NULL
10	NULL
,	NULL
31	NULL
)	NULL
.	NULL

Washed	NULL
blots	NULL
were	NULL
exposed	NULL
to	NULL
Cronex	NULL
4	NULL
films	NULL
(	NULL
Du	NULL
Pont	NULL
)	NULL
.	NULL

Multiple	NULL
2-	NULL
or	NULL
3-fold	NULL
exposures	NULL
for	NULL
each	NULL
blot	NULL
were	NULL
performed	NULL
,	NULL
and	NULL
the	NULL
films	NULL
with	NULL
signals	NULL
in	NULL
the	NULL
linear	NULL
range	NULL
were	NULL
scanned	NULL
,	NULL
where	NULL
appropriate	NULL
(	NULL
10	NULL
)	NULL
.	NULL

mRNA	NULL
Decay	NULL
and	NULL
Transcription	NULL
Rate	NULL
Measurements-mRNA	NULL
decay	NULL
was	NULL
measured	NULL
essentially	NULL
as	NULL
described	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Monocytes	NULL
were	NULL
stimulated	NULL
with	NULL
500	NULL
ng/ml	NULL
LPS	NULL
or	NULL
100	NULL
ng/ml	NULL
OA	NULL
for	NULL
2	NULL
h	NULL
followed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
10	NULL
ug/ml	NULL
actinomycin	NULL
D.	NULL
Cells	NULL
were	NULL
harvested	NULL
at	NULL
the	NULL
indicated	NULL
time	NULL
points	NULL
after	NULL
actinomycin	NULL
D	NULL
addition	NULL
and	NULL
their	NULL
RNA	NULL
analyzed	NULL
as	NULL
described	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Nuclear	NULL
run-on	NULL
was	NULL
performed	NULL
essentially	NULL
as	NULL
described	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
stimulated	NULL
for	NULL
2	NULL
h	NULL
followed	NULL
by	NULL
the	NULL
isolation	NULL
of	NULL
nuclei	NULL
by	NULL
Dounce	NULL
homogenization	NULL
.	NULL

The	NULL
run-on	NULL
reaction	NULL
was	NULL
performed	NULL
with	NULL
[	NULL
a	NULL
«	NULL
-	NULL
``	NULL
P	NULL
]	NULL
UTP	NULL
(	NULL
Du	NULL
Pont-New	NULL
England	NULL
Nuclear	NULL
,	NULL
3,000	NULL
Ci/mmol	NULL
)	NULL
,	NULL
and	NULL
isolated	NULL
RNA	NULL
was	NULL
hybridized	NULL
to	NULL
the	NULL
cDNA	NULL
probes	NULL
immobilized	NULL
on	NULL
GeneScreen	NULL
Plus	NULL
.	NULL

cDNA	NULL
inserts	NULL
were	NULL
used	NULL
for	NULL
the	NULL
IL-18	NULL
,	NULL
IL-1a	NULL
,	NULL
and	NULL
IL-6	NULL
probes	NULL
.	NULL

Blots	NULL
were	NULL
exposed	NULL
to	NULL
films	NULL
as	NULL
described	NULL
for	NULL
Northern	NULL
blots	NULL
.	NULL

Immunoprecipitation	NULL
of	NULL
Labeled	NULL
IL-1-Monocytes	NULL
were	NULL
washed	NULL
in	NULL
cold	NULL
phosphate-buffered	NULL
saline	NULL
and	NULL
labeled	NULL
with	NULL
[	NULL
*	NULL
``	NULL
S	NULL
)	NULL
Met	NULL
(	NULL
Du	NULL
Pont-New	NULL
England	NULL
Nuclear	NULL
,	NULL
1,000	NULL
Ci/mmol	NULL
!	NULL
)	NULL

in	NULL
Met-free	NULL
RPMI	NULL
1640	NULL
containing	NULL
10	NULL
%	NULL
dialyzed	NULL
fetal	NULL
calf	NULL
serum	NULL
essentially	NULL
as	NULL
described	NULL
(	NULL
10	NULL
)	NULL
.	NULL

To	NULL
maintain	NULL
cell	NULL
viability	NULL
,	NULL
the	NULL
concentration	NULL
of	NULL
OA	NULL
was	NULL
used	NULL
at	NULL
50	NULL
ng/ml	NULL
.	NULL

``	NULL
P	NULL
;	NULL
(	NULL
Du	NULL
Pont-New	NULL
England	NULL
Nuclear	NULL
,	NULL
carrier-free	NULL
)	NULL
labeling	NULL
(	NULL
200	NULL
uCi/m	NULL
!	NULL
)	NULL

was	NULL
performed	NULL
in	NULL
phosphate-free	NULL
RPMI	NULL
1640	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
dialyzed	NULL
against	NULL
Hank	NULL
's	NULL
balanced	NULL
salt	NULL
solution	NULL
without	NULL
phosphate	NULL
.	NULL

Cells	NULL
were	NULL
prelabeled	NULL
with	NULL
P	NULL
;	NULL
for	NULL
2	NULL
h	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
stimulants	NULL
.	NULL

All	NULL
labeling	NULL
was	NULL
for	NULL
6	NULL
h	NULL
at	NULL
5	NULL
X	NULL
10°	NULL
cells/ml	NULL
.	NULL

The	NULL
cultures	NULL
were	NULL
centrifuged	NULL
at	NULL
200	NULL
x	NULL
g	NULL
to	NULL
sediment	NULL
the	NULL
cells	NULL
.	NULL

Immunoprecipitation	NULL
of	NULL
IL-1a	NULL
and	NULL
IL-18	NULL
from	NULL
cell	NULL
pellet	NULL
lysates	NULL
and	NULL
supernatants	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Lactate	NULL
Dehydrogenase	NULL
Activity-Lactate	NULL
dehydrogenase	NULL
activities	NULL
in	NULL
supernatants	NULL
or	NULL
cell	NULL
lysates	NULL
were	NULL
measured	NULL
by	NULL
the	NULL
decrease	NULL
in	NULL
Azo	NULL
in	NULL
a	NULL
reaction	NULL
mixture	NULL
containing	NULL
0.2	NULL
M	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.3	NULL
,	NULL
0.2	NULL
mm	NULL
NADH	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
sodium	NULL
pyruvate	NULL
at	NULL
room	NULL
temperature	NULL
as	NULL
described	NULL
(	NULL
Worthington	NULL
manual	NULL
)	NULL
.	NULL

One	NULL
unit	NULL
is	NULL
defined	NULL
as	NULL
the	NULL
activity	NULL
that	NULL
oxidizes	NULL
1	NULL
umol	NULL
of	NULL
NADH/min	NULL
under	NULL
these	NULL
assay	NULL
conditions	NULL
.	NULL

For	NULL
supernatants	NULL
,	NULL
the	NULL
lactate	NULL
dehydrogenase	NULL
activities	NULL
at	NULL
zero	NULL
time	NULL
were	NULL
subtracted	NULL
from	NULL
those	NULL
at	NULL
other	NULL
time	NULL
points	NULL
.	NULL

Phagocytic	NULL
and	NULL
Pinocytic	NULL
Rate	NULL
Measurements-Phagocytosis	NULL
of	NULL
immunoglobulin	NULL
G-coated	NULL
sheep	NULL
erythrocytes	NULL
was	NULL
performed	NULL
essentially	NULL
as	NULL
described	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Monocytes	NULL
were	NULL
plated	NULL
on	NULL
glass	NULL
coverslips	NULL
in	NULL
16-mm	NULL
wells	NULL
at	NULL
1	NULL
X	NULL
10°	NULL
cells/well	NULL
,	NULL
allowed	NULL
to	NULL
adhere	NULL
for	NULL
1	NULL
h	NULL
,	NULL
and	NULL
5803	NULL
pretreated	NULL
with	NULL
drugs	NULL
for	NULL
1	NULL
h	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
particles	NULL
for	NULL
an	NULL
additional	NULL
hour	NULL
.	NULL

Phagocytosis	NULL
was	NULL
scored	NULL
microscopically	NULL
and	NULL
expressed	NULL
as	NULL
phagocytic	NULL
index	NULL
,	NULL
the	NULL
total	NULL
number	NULL
of	NULL
erythrocytes	NULL
ingested	NULL
by	NULL
100	NULL
monocytes	NULL
.	NULL

Experiments	NULL
measuring	NULL
monocyte	NULL
pinocytic	NULL
rate	NULL
of	NULL
horseradish	NULL
peroxidase	NULL
was	NULL
performed	NULL
as	NULL
in	NULL
phagocytosis	NULL
,	NULL
except	NULL
that	NULL
3	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
plated/well	NULL
.	NULL

Because	NULL
monocytes	NULL
detached	NULL
from	NULL
plastic	NULL
in	NULL
culture	NULL
,	NULL
the	NULL
wells	NULL
were	NULL
treated	NULL
with	NULL
poly-L-lysine	NULL
(	NULL
Sigma	NULL
)	NULL
to	NULL
increase	NULL
cell	NULL
adherence	NULL
.	NULL

Pinocytosis	NULL
was	NULL
performed	NULL
for	NULL
1	NULL
h	NULL
using	NULL
1	NULL
mg/ml	NULL
horseradish	NULL
peroxidase	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
pinocytosed	NULL
enzyme	NULL
was	NULL
measured	NULL
as	NULL
described	NULL
(	NULL
34	NULL
)	NULL
.	NULL

RESULTS	NULL
OA	NULL
Stimulation	NULL
of	NULL
IL-16	NULL
and	NULL
IL-1a	NULL
mRNA	NULL
Accumulation	NULL
in	NULL
Human	NULL
Monocytes	NULL
and	NULL
Myeloid	NULL
Cell	NULL
Lines-We	NULL
have	NULL
observed	NULL
previously	NULL
that	NULL
OA	NULL
and	NULL
calyculin	NULL
A	NULL
stimulated	NULL
IL-1	NULL
mRNA	NULL
accumulation	NULL
(	NULL
26	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
further	NULL
the	NULL
role	NULL
of	NULL
protein	NULL
phosphatases	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
IL-1	NULL
production	NULL
,	NULL
the	NULL
optimal	NULL
OA	NULL
dose	NULL
and	NULL
time	NULL
course	NULL
for	NULL
IL-la	NULL
and	NULL
stimulation	NULL
were	NULL
analyzed	NULL
by	NULL
Northern	NULL
blot	NULL
.	NULL

OA	NULL
stimulated	NULL
the	NULL
increase	NULL
in	NULL
IL-18	NULL
mRNA	NULL
accumulation	NULL
optimally	NULL
between	NULL
100	NULL
and	NULL
200	NULL
ng/ml	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
higher	NULL
doses	NULL
than	NULL
200	NULL
ng/ml	NULL
caused	NULL
some	NULL
cells	NULL
to	NULL
lose	NULL
viability	NULL
after	NULL
a	NULL
4-h	NULL
incubation	NULL
.	NULL

The	NULL
inhibition	NULL
of	NULL
LPS-induced	NULL
IL-1	NULL
$	NULL
9	NULL
,	NULL
IL-1	NULL
@	NULL
«	NULL
,	NULL
and	NULL
IL-6	NULL
mRNA	NULL
expression	NULL
by	NULL
high	NULL
calyculin	NULL
A	NULL
doses	NULL
(	NULL
26	NULL
)	NULL
was	NULL
not	NULL
observed	NULL
with	NULL
OA	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
IL-1	NULL
$	NULL
,	NULL
IL-1a	NULL
and	NULL
IL-6	NULL
mRNA	NULL
accumulation	NULL
was	NULL
only	NULL
slightly	NULL
stimulated	NULL
.	NULL

Whereas	NULL
OA	NULL
and	NULL
LPS	NULL
were	NULL
synergistic	NULL
in	NULL
increasing	NULL
steady-state	NULL
level	NULL
of	NULL
TNF	NULL
mRNA	NULL
(	NULL
26	NULL
)	NULL
,	NULL
such	NULL
synergy	NULL
did	NULL
not	NULL
occur	NULL
with	NULL
IL-1	NULL
,	NULL
IL-1a	NULL
,	NULL
and	NULL
IL-6	NULL
mRNA	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

The	NULL
stimulation	NULL
of	NULL
IL-18	NULL
and	NULL
TNF	NULL
mRNA	NULL
expression	NULL
by	NULL
OA	NULL
was	NULL
further	NULL
compared	NULL
in	NULL
two	NULL
myeloid	NULL
cell	NULL
lines	NULL
shown	NULL
to	NULL
express	NULL
high	NULL
inducible	NULL
levels	NULL
of	NULL
these	NULL
two	NULL
mRNA	NULL
(	NULL
10	NULL
,	NULL
30	NULL
;	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
C	NULL
and	NULL
D	NULL
)	NULL
.	NULL

In	NULL
HL-60	NULL
,	NULL
there	NULL
was	NULL
some	NULL
basal	NULL
IL-18	NULL
and	NULL
no	NULL
TNF	NULL
mRNA	NULL
accumulation	NULL
in	NULL
unstimulated	NULL
cells	NULL
,	NULL
LPS	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
a	NULL
poor	NULL
stimulant	NULL
of	NULL
IL-1	NULL
mRNA	NULL
expression	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
10	NULL
)	NULL
.	NULL

A	NULL
suboptimal	NULL
dose	NULL
of	NULL
PMA	NULL
induced	NULL
little	NULL
increase	NULL
in	NULL
these	NULL
mRNAs	NULL
.	NULL

OA	NULL
and	NULL
calyculin	NULL
A	NULL
increased	NULL
the	NULL
accumulation	NULL
of	NULL
both	NULL
messages	NULL
.	NULL

Calyculin	NULL
A	NULL
was	NULL
a	NULL
better	NULL
stimulant	NULL
than	NULL
OA	NULL
in	NULL
increasing	NULL
IL-1	NULL
$	NULL
mRNA	NULL
accumulation	NULL
,	NULL
although	NULL
they	NULL
have	NULL
comparable	NULL
effects	NULL
on	NULL
TNF	NULL
mRNA	NULL
accumulation	NULL
.	NULL

These	NULL
results	NULL
showed	NULL
the	NULL
difference	NULL
in	NULL
gene-induc-ing	NULL
effects	NULL
between	NULL
OA	NULL
and	NULL
calyculin	NULL
A	NULL
.	NULL

Little	NULL
synergy	NULL
was	NULL
observed	NULL
for	NULL
PMA	NULL
with	NULL
either	NULL
OA	NULL
or	NULL
calyculin	NULL
A	NULL
.	NULL

In	NULL
ML-1	NULL
cells	NULL
,	NULL
which	NULL
produce	NULL
the	NULL
highest	NULL
level	NULL
of	NULL
IL-18	NULL
mRNA	NULL
in	NULL
several	NULL
myelomonocytic	NULL
cell	NULL
lines	NULL
examined	NULL
(	NULL
10	NULL
)	NULL
,	NULL
OA	NULL
was	NULL
a	NULL
relatively	NULL
poor	NULL
stimulant	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
this	NULL
message	NULL
(	NULL
Fig	NULL
.	NULL

1D	NULL
)	NULL
.	NULL

OA	NULL
and	NULL
PMA	NULL
were	NULL
not	NULL
synergistic	NULL
in	NULL
stimulating	NULL
IL-1§	NULL
mRNA	NULL
accumulation	NULL
in	NULL
ML-1	NULL
cells	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
IL-1a	NULL
mRNA	NULL
in	NULL
these	NULL
cell	NULL
lines	NULL
was	NULL
weak	NULL
and	NULL
was	NULL
therefore	NULL
not	NULL
further	NULL
examined	NULL
.	NULL

Time	NULL
Course	NULL
of	NULL
IL-1	NULL
mRNA	NULL
Accumulation	NULL
Stimulated	NULL
by	NULL
OA-The	NULL
time	NULL
course	NULL
of	NULL
IL-18	NULL
and	NULL
IL-1a	NULL
mRNA	NULL
accumulation	NULL
in	NULL
OA-	NULL
or	NULL
OA	NULL
plus	NULL
LPS-stimulated	NULL
monocytes	NULL
was	NULL
examined	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
levels	NULL
of	NULL
both	NULL
IL-1	NULL
mRNA	NULL
peaked	NULL
between	NULL
2	NULL
and	NULL
4	NULL
h	NULL
in	NULL
OA-stimulated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

IL-6	NULL
mRNA	NULL
increase	NULL
was	NULL
slower	NULL
and	NULL
was	NULL
still	NULL
increasing	NULL
at	NULL
4	NULL
h.	NULL
In	NULL
cells	NULL
stimulated	NULL
with	NULL
LPS	NULL
plus	NULL
OA	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
,	NULL
the	NULL
IL-18	NULL
mRNA	NULL
level	NULL
peaked	NULL
earlier	NULL
than	NULL
in	NULL
OA-stimulated	NULL
cells	NULL
and	NULL
reached	NULL
plateau	NULL
level	NULL
at	NULL
1	NULL
h.	NULL
IL-1a	NULL
and	NULL
IL-6	NULL
mRNA	NULL
accumulation	NULL
peaked	NULL
at	NULL
about	NULL
2	NULL
h.	NULL
No	NULL
appreciable	NULL
change	NULL
in	NULL
B-actin	NULL
mRNA	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
28	NULL
S	NULL
rRNA	NULL
levels	NULL
was	NULL
observed	NULL
during	NULL
the	NULL
experiment	NULL
.	NULL

Decay	NULL
of	NULL
IL-1	NULL
mRNA	NULL
in	NULL
the	NULL
Presence	NULL
of	NULL
OA-The	NULL
stimulation	NULL
of	NULL
IL-1	NULL
mRNA	NULL
accumulation	NULL
may	NULL
be	NULL
a	NULL
result	NULL
of	NULL
mRNA	NULL
stabilization	NULL
.	NULL

This	NULL
was	NULL
examined	NULL
by	NULL
mRNA	NULL
decay	NULL
studies	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
TNF	NULL
mRNA	NULL
,	NULL
which	NULL
is	NULL
stabilized	NULL
by	NULL
OA	NULL
(	NULL
26	NULL
)	NULL
,	NULL
IL-1	NULL
and	NULL
IL-1a	NULL
mRNA	NULL
were	NULL
not	NULL
similarly	NULL
stabilized	NULL
.	NULL

The	NULL
half-lives	NULL
of	NULL
IL-1	NULL
mRNA	NULL
were	NULL
determined	NULL
to	NULL
be	NULL
between	NULL
5804	NULL
A	NULL
B	NULL
OA	NULL
<	NULL
<	NULL
3	NULL
:	NULL
l_1_ﬂ	NULL
a	NULL
+	NULL
w	NULL
-	NULL
50	NULL
100	NULL
200	NULL
o	NULL
a	NULL
0	NULL
J	NULL
-|	NULL
wa	NULL
|	NULL
**	NULL
we	NULL
-	NULL
--	NULL
an	NULL
wo	NULL
an	NULL
IL	NULL
-la	NULL
-	NULL
§	NULL
-	NULL
wap	NULL
<	NULL
=	NULL
wan	NULL
IL-6	NULL
-	NULL
.	NULL

w	NULL
@	NULL
n	NULL
-	NULL
__	NULL
@	NULL
-	NULL
e	NULL
28	NULL
S	NULL
-	NULL
w	NULL
=	NULL
»	NULL
ap	NULL
He	NULL
we	NULL
-h	NULL
wae	NULL
tip	NULL
wan	NULL
|	NULL
2	NULL
3	NULL
4	NULL
5	NULL
1	NULL
2	NULL
3	NULL
4	NULL
C	NULL
-	NULL
HL-60	NULL
D	NULL
-	NULL
ML-I1	NULL
ins	NULL
<	NULL
_	NULL
<	NULL
§	NULL
0	NULL
A	NULL
P	NULL
+	NULL
OA	NULL
go	NULL
?	NULL

m	NULL
--	NULL
--	NULL
4	NULL
m	NULL
--	NULL
--	NULL
A	NULL
o	NULL
a	NULL
3	NULL
§	NULL
&	NULL
i	NULL
w	NULL
I0	NULL
30100a	NULL
.	NULL

10	NULL
30	NULL
100	NULL
|L—|B—~—_-	NULL
'	NULL
o	NULL
'	NULL
=	NULL
e	NULL
a	NULL
0	NULL
a	NULL
TNF	NULL
-	NULL
aa	NULL
=	NULL
we	NULL
l.	NULL
|	NULL
2	NULL
3	NULL
4	NULL
506	NULL
I	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7T	NULL
8	NULL
FiG	NULL
.	NULL

1	NULL
.	NULL

Stimulation	NULL
of	NULL
IL-1	NULL
}	NULL
and	NULL
IL-1a	NULL
mRNA	NULL
accumulation	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
and	NULL
myeloid	NULL
cell	NULL
lines	NULL
treated	NULL
with	NULL
protein	NULL
phosphatase	NULL
1	NULL
and	NULL
2A	NULL
inhibitors	NULL
.	NULL

In	NULL
panels	NULL
A	NULL
and	NULL
B	NULL
,	NULL
human	NULL
monocytes	NULL
at	NULL
5	NULL
x	NULL
10°/ml	NULL
(	NULL
10	NULL
x	NULL
10°	NULL
cells/sample	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
the	NULL
indicated	NULL
agents	NULL
for	NULL
2	NULL
h.	NULL
In	NULL
panels	NULL
C	NULL
and	NULL
D	NULL
,	NULL
the	NULL
cell	NULL
lines	NULL
were	NULL
similarly	NULL
stimulated	NULL
.	NULL

The	NULL
concentration	NULL
of	NULL
reagents	NULL
were	NULL
:	NULL
L	NULL
(	NULL
LPS	NULL
)	NULL
,	NULL
100	NULL
ng/ml	NULL
;	NULL
OA	NULL
,	NULL
100	NULL
ng/ml	NULL
in	NULL
panel	NULL
B	NULL
and	NULL
200	NULL
ng/ml	NULL
in	NULL
panel	NULL
C	NULL
;	NULL
calyculin	NULL
A	NULL
,	NULL
200	NULL
ng/ml	NULL
;	NULL
and	NULL
P	NULL
(	NULL
PMA	NULL
)	NULL
,	NULL
1	NULL
ng/ml	NULL
in	NULL
panel	NULL
C	NULL
and	NULL
3	NULL
ng/ml	NULL
in	NULL
panel	NULL
D.	NULL
Lane	NULL
C	NULL
is	NULL
the	NULL
control	NULL
lane	NULL
.	NULL

The	NULL
drug	NULL
concentrations	NULL
in	NULL
panels	NULL
A	NULL
and	NULL
D	NULL
are	NULL
in	NULL
ng/ml	NULL
.	NULL

Northern	NULL
blot	NULL
of	NULL
total	NULL
RNA	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
``	NULL
and	NULL
detected	NULL
with	NULL
the	NULL
indicated	NULL
probes	NULL
as	NULL
described	NULL
(	NULL
10	NULL
)	NULL
.	NULL

The	NULL
whole	NULL
sample	NULL
was	NULL
used	NULL
in	NULL
panels	NULL
A	NULL
and	NULL
B	NULL
,	NULL
and	NULL
10	NULL
ug/lane	NULL
was	NULL
used	NULL
in	NULL
panels	NULL
C	NULL
and	NULL
D.	NULL
The	NULL
experiments	NULL
in	NULL
panels	NULL
A	NULL
and	NULL
B	NULL
were	NULL
performed	NULL
three	NULL
times	NULL
and	NULL
those	NULL
of	NULL
panels	NULL
C	NULL
and	NULL
D	NULL
twice	NULL
.	NULL

35	NULL
and	NULL
45	NULL
min	NULL
compared	NULL
with	NULL
about	NULL
17	NULL
min	NULL
for	NULL
TNF	NULL
mRNA	NULL
in	NULL
the	NULL
same	NULL
experiments	NULL
.	NULL

The	NULL
mode	NULL
of	NULL
IL-1la	NULL
mRNA	NULL
decay	NULL
is	NULL
of	NULL
interest	NULL
.	NULL

In	NULL
repeated	NULL
experiments	NULL
,	NULL
two	NULL
bands	NULL
with	NULL
higher	NULL
and	NULL
lower	NULL
migration	NULL
than	NULL
that	NULL
of	NULL
the	NULL
putative	NULL
IL-l	NULL
«	NULL
mRNA	NULL
were	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

Effects	NULL
of	NULL
OA	NULL
on	NULL
the	NULL
Transcription	NULL
Rate	NULL
of	NULL
IL-1	NULL
mRNA-The	NULL
transcription	NULL
rate	NULL
stimulation	NULL
by	NULL
OA	NULL
in	NULL
monocytes	NULL
was	NULL
examined	NULL
by	NULL
nuclear	NULL
run-on	NULL
experiments	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

No	NULL
signal	NULL
was	NULL
observed	NULL
with	NULL
the	NULL
control	NULL
plasmid	NULL
probe	NULL
.	NULL

The	NULL
signal	NULL
for	NULL
IL-13	NULL
was	NULL
100-	NULL
200-fold	NULL
higher	NULL
than	NULL
that	NULL
of	NULL
IL-1l1a	NULL
and	NULL
IL-6	NULL
.	NULL

Low	NULL
basal	NULL
IL-1a	NULL
,	NULL
and	NULL
IL-6	NULL
transcription	NULL
rates	NULL
were	NULL
observed	NULL
in	NULL
control	NULL
cells	NULL
.	NULL

Both	NULL
OA	NULL
and	NULL
LPS	NULL
stimulated	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
three	NULL
mRNA	NULL
.	NULL

LPS	NULL
and	NULL
OA	NULL
strongly	NULL
stimulated	NULL
IL-1	NULL
$	NULL
transcription	NULL
.	NULL

This	NULL
stimulation	NULL
was	NULL
weaker	NULL
for	NULL
IL-la	NULL
and	NULL
IL-6	NULL
,	NULL
especially	NULL
for	NULL
OA	NULL
stimulation	NULL
,	NULL
which	NULL
resulted	NULL
in	NULL
only	NULL
slight	NULL
transcriptional	NULL
increases	NULL
above	NULL
control	NULL
.	NULL

Stimulation	NULL
of	NULL
transcription	NULL
of	NULL
all	NULL
three	NULL
genes	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
LPS	NULL
and	NULL
OA	NULL
was	NULL
comparable	NULL
to	NULL
those	NULL
by	NULL
LPS	NULL
treatment	NULL
alone	NULL
.	NULL

These	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
mRNA	NULL
Okadaic	NULL
Acid	NULL
and	NULL
Calyculin	NULL
A	NULL
Stimulation	NULL
of	NULL
IL-1	NULL
Production	NULL
A	NULL
oA	NULL
B	NULL
L+	NULL
oA	NULL
L	NULL
Time	NULL
(	NULL
h	NULL
)	NULL
0	NULL
|	NULL
2	NULL
4	NULL
0	NULL
1	NULL
2	NULL
2	NULL
4	NULL
le-	NULL
-	NULL
o	NULL
#	NULL
#	NULL
Ur	NULL
IL-la	NULL
-	NULL
®	NULL
we	NULL
-_-	NULL
a	NULL
#	NULL
«	NULL
-IL-6	NULL
-	NULL
__	NULL
=	NULL
»	NULL
as	NULL
28	NULL
5	NULL
-	NULL
w	NULL
we	NULL
wn	NULL
-	NULL
-p	NULL
``	NULL
’	NULL
.	NULL

1	NULL
2	NULL
3	NULL
4	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Time	NULL
course	NULL
of	NULL
IL-18	NULL
and	NULL
IL-1l	NULL
«	NULL
mRNA	NULL
expression	NULL
in	NULL
monocytes	NULL
stimulated	NULL
by	NULL
OA	NULL
and	NULL
OA	NULL
plus	NULL
LPS	NULL
.	NULL

Northern	NULL
blot	NULL
of	NULL
total	NULL
RNA	NULL
from	NULL
monocytes	NULL
stimulated	NULL
with	NULL
100	NULL
ng/ml	NULL
OA	NULL
(	NULL
panel	NULL
A	NULL
)	NULL
or	NULL
100	NULL
ng/ml	NULL
OA	NULL
plus	NULL
100	NULL
ng/ml	NULL
LPS	NULL
(	NULL
panel	NULL
B	NULL
)	NULL
for	NULL
the	NULL
time	NULL
period	NULL
indicated	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

In	NULL
lane	NULL
3	NULL
,	NULL
panel	NULL
B	NULL
,	NULL
the	NULL
stimulation	NULL
was	NULL
100	NULL
ng/ml	NULL
LPS	NULL
for	NULL
2	NULL
h.	NULL
For	NULL
each	NULL
sample	NULL
,	NULL
10	NULL
x	NULL
10°	NULL
cells	NULL
were	NULL
used	NULL
.	NULL

One	NULL
of	NULL
two	NULL
similar	NULL
experiments	NULL
is	NULL
shown	NULL
.	NULL

A	NULL
LPS	NULL
OA	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
O	NULL
2040	NULL
60	NULL
O	NULL
20	NULL
40	NULL
60	NULL
IL-IB	NULL
-	NULL
#	NULL
#	NULL
«	NULL
«	NULL
»	NULL
«	NULL
as	NULL
6B	NULL
as	NULL
we	NULL
un	NULL
Relative	NULL
Absorbance	NULL
(	NULL
%	NULL
Control	NULL
)	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
Fic	NULL
.	NULL

3.	NULL
and	NULL
IL-1	NULL
«	NULL
mRNA	NULL
decay	NULL
in	NULL
human	NULL
monocytes	NULL
stimulated	NULL
with	NULL
LPS	NULL
or	NULL
OA	NULL
.	NULL

Human	NULL
monocytes	NULL
were	NULL
stimulated	NULL
for	NULL
2	NULL
h	NULL
with	NULL
LPS	NULL
(	NULL
panel	NULL
A	NULL
,	NULL
lanes	NULL
1-4	NULL
)	NULL
or	NULL
OA	NULL
(	NULL
lanes	NULL
5-8	NULL
)	NULL
followed	NULL
by	NULL
mRNA	NULL
decay	NULL
measurement	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

Northern	NULL
blot	NULL
analysis	NULL
of	NULL
the	NULL
cellular	NULL
RNA	NULL
was	NULL
performed	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

The	NULL
absorbance	NULL
intensities	NULL
of	NULL
IL-1	NULL
in	NULL
appropriately	NULL
exposed	NULL
films	NULL
were	NULL
scanned	NULL
by	NULL
densitometry	NULL
and	NULL
normalized	NULL
against	NULL
that	NULL
of	NULL
28	NULL
S	NULL
RNA	NULL
in	NULL
the	NULL
same	NULL
samples	NULL
as	NULL
described	NULL
(	NULL
10	NULL
)	NULL
.	NULL

These	NULL
relative	NULL
absorbance	NULL
intensities	NULL
for	NULL
IL-18	NULL
and	NULL
IL-l	NULL
«	NULL
mRNA	NULL
were	NULL
plotted	NULL
in	NULL
a	NULL
semilogarithmic	NULL
plot	NULL
in	NULL
panel	NULL
B	NULL
.	NULL

The	NULL
lines	NULL
were	NULL
fitted	NULL
by	NULL
linear	NULL
regression	NULL
using	NULL
the	NULL
program	NULL
Sigmaplot	NULL
.	NULL

The	NULL
results	NULL
are	NULL
representative	NULL
of	NULL
two	NULL
similar	NULL
experiments	NULL
.	NULL

accumulation	NULL
measurements	NULL
showing	NULL
strong	NULL
stimulation	NULL
of	NULL
IL-183	NULL
mRNA	NULL
increase	NULL
but	NULL
much	NULL
weaker	NULL
stimulation	NULL
of	NULL
that	NULL
of	NULL
IL-1a	NULL
and	NULL
IL-6	NULL
by	NULL
OA	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

The	NULL
transcription	NULL
rates	NULL
of	NULL
control	NULL
genes	NULL
which	NULL
included	NULL
B-actin	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
,	NULL
triose-	NULL
Okadaic	NULL
Acid	NULL
and	NULL
Calyculin	NULL
A	NULL
Stimulation	NULL
of	NULL
IL-1	NULL
Production	NULL
C	NULL
L	NULL
OA	NULL
-	NULL
L+OA	NULL
pSKI1	NULL
_-IL-IB	NULL
-	NULL
-_	NULL
«	NULL
*=	NULL
cars	NULL
ceange	NULL
proce	NULL
IL-Ia	NULL
=-	NULL
foal	NULL
come	NULL
e	NULL
IL-6	NULL
-	NULL
sms	NULL
B-Actin	NULL
_-	NULL
womens	NULL
I	NULL
2	NULL
3	NULL
4	NULL
200	NULL
©	NULL
O	NULL
(	NULL
E150	NULL
17	NULL
5	NULL
8	NULL
100	NULL
<	NULL
o	NULL
.2	NULL
#	NULL
so	NULL
$	NULL
7	NULL
IL-10	NULL
.	NULL

FiG	NULL
.	NULL

4	NULL
.	NULL

Nuclear	NULL
run-on	NULL
of	NULL
human	NULL
monocytes	NULL
stimulated	NULL
with	NULL
OA	NULL
and	NULL
LPS	NULL
.	NULL

Nuclear	NULL
run-on	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

Monocytes	NULL
(	NULL
30	NULL
x	NULL
10°	NULL
cells/sample	NULL
;	NULL
5	NULL
x	NULL
10°	NULL
cells/ml	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
100	NULL
ng/ml	NULL
LPS	NULL
(	NULL
L	NULL
)	NULL
,	NULL
100	NULL
ng/	NULL
ml	NULL
OA	NULL
,	NULL
or	NULL
their	NULL
combination	NULL
for	NULL
2	NULL
h	NULL
followed	NULL
by	NULL
the	NULL
isolation	NULL
of	NULL
nuclei	NULL
for	NULL
the	NULL
run-on	NULL
reaction	NULL
.	NULL

The	NULL
signals	NULL
for	NULL
IL-13	NULL
(	NULL
panel	NULL
A	NULL
)	NULL
were	NULL
from	NULL
a	NULL
4-h	NULL
exposure	NULL
,	NULL
whereas	NULL
the	NULL
bands	NULL
for	NULL
the	NULL
other	NULL
genes	NULL
were	NULL
from	NULL
a	NULL
4-day	NULL
exposure	NULL
.	NULL

The	NULL
signal	NULL
intensities	NULL
for	NULL
each	NULL
sample	NULL
were	NULL
scanned	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

The	NULL
relative	NULL
absorbance	NULL
values	NULL
were	NULL
the	NULL
ratio	NULL
of	NULL
cytokine	NULL
signal	NULL
intensities	NULL
normalized	NULL
against	NULL
that	NULL
of	NULL
$	NULL
-actin	NULL
.	NULL

They	NULL
were	NULL
plotted	NULL
in	NULL
panel	NULL
B	NULL
.	NULL

The	NULL
vertical	NULL
scale	NULL
on	NULL
the	NULL
left	NULL
is	NULL
for	NULL
IL-18	NULL
and	NULL
that	NULL
on	NULL
the	NULL
right	NULL
for	NULL
IL-la	NULL
and	NULL
IL-6	NULL
genes	NULL
.	NULL

The	NULL
bars	NULL
are	NULL
:	NULL
0	NULL
,	NULL
control	NULL
;	NULL
&	NULL
,	NULL
LPS	NULL
;	NULL
0	NULL
,	NULL
OA	NULL
;	NULL
and	NULL
O	NULL
,	NULL
LPS	NULL
+	NULL
OA	NULL
.	NULL

One	NULL
of	NULL
three	NULL
similar	NULL
experiments	NULL
is	NULL
shown	NULL
.	NULL

phosphate	NULL
isomerase	NULL
,	NULL
and	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
I	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
were	NULL
not	NULL
changed	NULL
appreciably	NULL
by	NULL
the	NULL
drugs	NULL
.	NULL

Stimulation	NULL
of	NULL
c-jun	NULL
and	NULL
junB	NULL
mRNA	NULL
Accumulation	NULL
by	NULL
OA	NULL
and	NULL
Calyculin	NULL
A-Increases	NULL
in	NULL
AP-1	NULL
binding	NULL
activity	NULL
during	NULL
OA	NULL
stimulation	NULL
may	NULL
be	NULL
important	NULL
for	NULL
the	NULL
enhancement	NULL
of	NULL
the	NULL
transcription	NULL
rate	NULL
of	NULL
IL-1	NULL
genes	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Because	NULL
OA	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
increase	NULL
AP-1	NULL
binding	NULL
activities	NULL
(	NULL
26	NULL
,	NULL
27	NULL
)	NULL
,	NULL
and	NULL
c-jun	NULL
and	NULL
junB	NULL
have	NULL
opposite	NULL
effects	NULL
on	NULL
gene	NULL
regulation	NULL
(	NULL
36	NULL
,	NULL
37	NULL
)	NULL
,	NULL
the	NULL
stimulation	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
jun-related	NULL
mRNA	NULL
species	NULL
by	NULL
OA	NULL
and	NULL
calyculin	NULL
A	NULL
was	NULL
examined	NULL
.	NULL

Time	NULL
course	NULL
studies	NULL
showed	NULL
that	NULL
stimulation	NULL
of	NULL
c-jun	NULL
mRNA	NULL
expression	NULL
by	NULL
OA	NULL
peaked	NULL
between	NULL
2	NULL
and	NULL
4	NULL
h	NULL
in	NULL
human	NULL
monocytes	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
dose-response	NULL
of	NULL
OA	NULL
and	NULL
calyculin	NULL
A	NULL
stimulation	NULL
of	NULL
jun-related	NULL
mRNA	NULL
expression	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

There	NULL
was	NULL
little	NULL
basal	NULL
c-jun	NULL
mRNA	NULL
expression	NULL
.	NULL

OA	NULL
and	NULL
calyculin	NULL
A	NULL
markedly	NULL
increased	NULL
its	NULL
accumulation	NULL
at	NULL
100	NULL
and	NULL
30	NULL
ng/ml	NULL
,	NULL
respectively	NULL
.	NULL

junD	NULL
mRNA	NULL
,	NULL
although	NULL
at	NULL
much	NULL
lower	NULL
levels	NULL
,	NULL
was	NULL
similarly	NULL
induced	NULL
.	NULL

There	NULL
was	NULL
an	NULL
appreciable	NULL
amount	NULL
of	NULL
junB	NULL
mRNA	NULL
expression	NULL
in	NULL
resting	NULL
cells	NULL
.	NULL

OA	NULL
and	NULL
calyculin	NULL
A	NULL
further	NULL
increased	NULL
this	NULL
expression	NULL
at	NULL
100	NULL
and	NULL
30	NULL
ng/ml	NULL
,	NULL
respectively	NULL
,	NULL
but	NULL
not	NULL
at	NULL
lower	NULL
drug	NULL
concentrations	NULL
.	NULL

AP-1	NULL
binding	NULL
proteins	NULL
are	NULL
composed	NULL
of	NULL
Jun-Jun	NULL
or	NULL
Fos-Jun	NULL
dimers	NULL
(	NULL
15	NULL
)	NULL
.	NULL

The	NULL
contribution	NULL
of	NULL
increases	NULL
in	NULL
mRNA	NULL
accumulation	NULL
of	NULL
fos-related	NULL
genes	NULL
to	NULL
the	NULL
OA	NULL
stimulation	NULL
of	NULL
AP-1	NULL
5805	NULL
A	NULL
OA	NULL
L+OA	NULL
Calyculin	NULL
L+Calyculin	NULL
C	NULL
L	NULL
1	NULL
101001	NULL
10	NULL
100	NULL
C	NULL
L	NULL
3	NULL
1030	NULL
3	NULL
1030	NULL
c-jun	NULL
-	NULL
s	NULL
w	NULL
=-	NULL
ao	NULL
we	NULL
3	NULL
,	NULL
``	NULL
``	NULL
p	NULL
p	NULL
junD	NULL
-	NULL
¥a	NULL
;	NULL
=	NULL
we	NULL
*	NULL
w	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
FiG	NULL
.	NULL

5	NULL
.	NULL

Expression	NULL
of	NULL
jun-related	NULL
mRNA	NULL
in	NULL
human	NULL
monocytes	NULL
stimulated	NULL
with	NULL
OA	NULL
(	NULL
panel	NULL
A	NULL
)	NULL
and	NULL
calyculin	NULL
A	NULL
(	NULL
panel	NULL
B	NULL
)	NULL
.	NULL

Northern	NULL
blots	NULL
of	NULL
total	NULL
RNA	NULL
from	NULL
monocytes	NULL
stimulated	NULL
for	NULL
2	NULL
h	NULL
with	NULL
the	NULL
indicated	NULL
agents	NULL
in	NULL
ng/ml	NULL
were	NULL
performed	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

LPS	NULL
was	NULL
used	NULL
at	NULL
100	NULL
ng/ml	NULL
.	NULL

Each	NULL
sample	NULL
was	NULL
from	NULL
10	NULL
x	NULL
10°	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
similar	NULL
experiments	NULL
.	NULL

A	NULL
OA	NULL
L+OA	NULL
C	NULL
L	NULL
1	NULL
101001	NULL
10	NULL
100	NULL
a	NULL
;	NULL
i	NULL
ee	NULL
~	NULL
th	NULL
uy	NULL
B	NULL
H	NULL
we	NULL
w	NULL
t	NULL
C	NULL
CL	NULL
_	NULL
OA	NULL
(	NULL
h	NULL
)	NULL
0	NULL
2	NULL
2051	NULL
2	NULL
Cal.A	NULL
L+CalA	NULL
C	NULL
L	NULL
510303	NULL
10	NULL
30	NULL
ras	NULL
fosB	NULL
-	NULL
m	NULL
Fra	NULL
-l	NULL
-	NULL
we	NULL
as	NULL
ws	NULL
28	NULL
S	NULL
-~	NULL
.	NULL

aa	NULL
un	NULL
ant	NULL
uo	NULL
we	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
FiG	NULL
.	NULL

6	NULL
.	NULL

Expression	NULL
of	NULL
fos-related	NULL
mRNA	NULL
in	NULL
human	NULL
monocytes	NULL
stimulated	NULL
with	NULL
OA	NULL
and	NULL
calyculin	NULL
A	NULL
.	NULL

Panels	NULL
A	NULL
and	NULL
B	NULL
show	NULL
the	NULL
dose	NULL
dependence	NULL
of	NULL
OA	NULL
(	NULL
panel	NULL
A	NULL
)	NULL
and	NULL
calyculin	NULL
A	NULL
(	NULL
panel	NULL
B	NULL
)	NULL
stimulation	NULL
of	NULL
c-fos	NULL
and	NULL
fosB	NULL
mRNA	NULL
accumulation	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
lanes	NULL
6-8	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
lanes	NULL
3-5	NULL
)	NULL
of	NULL
100	NULL
ng/ml	NULL
LPS	NULL
at	NULL
the	NULL
indicated	NULL
concentrations	NULL
(	NULL
ng/ml	NULL
)	NULL
of	NULL
phosphatase	NULL
inhibitors	NULL
.	NULL

fra-1	NULL
mRNA	NULL
signals	NULL
were	NULL
too	NULL
faint	NULL
to	NULL
show	NULL
,	NULL
but	NULL
increases	NULL
were	NULL
observed	NULL
at	NULL
the	NULL
highest	NULL
concentrations	NULL
of	NULL
drugs	NULL
used	NULL
.	NULL

Panel	NULL
C	NULL
shows	NULL
the	NULL
time	NULL
course	NULL
of	NULL
OA	NULL
stimulation	NULL
of	NULL
c-fos	NULL
,	NULL
fosB	NULL
,	NULL
and	NULL
fra-1	NULL
mRNA	NULL
expression	NULL
.	NULL

Monocytes	NULL
were	NULL
stimulated	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
and	NULL
Northern	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Experiments	NULL
in	NULL
panels	NULL
A	NULL
and	NULL
B	NULL
were	NULL
performed	NULL
three	NULL
times	NULL
and	NULL
that	NULL
in	NULL
panel	NULL
C	NULL
twice	NULL
.	NULL

binding	NULL
activities	NULL
was	NULL
examined	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

OA	NULL
and	NULL
calyculin	NULL
A	NULL
at	NULL
100	NULL
and	NULL
30	NULL
ng	NULL
,	NULL
respectively	NULL
,	NULL
stimulated	NULL
the	NULL
accumulation	NULL
of	NULL
c-fos	NULL
mRNA	NULL
,	NULL
and	NULL
no	NULL
further	NULL
stimulation	NULL
was	NULL
found	NULL
when	NULL
LPS	NULL
was	NULL
used	NULL
with	NULL
these	NULL
phosphatase	NULL
inhibitors	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
doubtful	NULL
that	NULL
increases	NULL
in	NULL
c-fos	NULL
mRNA	NULL
accumulation	NULL
led	NULL
to	NULL
the	NULL
early	NULL
increase	NULL
in	NULL
AP-1	NULL
binding	NULL
activities	NULL
in	NULL
OA-stimulated	NULL
cells	NULL
because	NULL
in	NULL
repeated	NULL
time	NULL
course	NULL
studies	NULL
,	NULL
basal	NULL
c-fos	NULL
mRNA	NULL
level	NULL
was	NULL
higher	NULL
than	NULL
that	NULL
in	NULL
OA-treated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
.	NULL

Despite	NULL
this	NULL
high	NULL
initial	NULL
mRNA	NULL
level	NULL
,	NULL
cells	NULL
incubated	NULL
in	NULL
culture	NULL
lost	NULL
c-fos	NULL
mRNA	NULL
rapidly	NULL
,	NULL
and	NULL
OA-stimulated	NULL
cells	NULL
incubated	NULL
for	NULL
the	NULL
same	NULL
time	NULL
period	NULL
contained	NULL
more	NULL
of	NULL
this	NULL
mRNA	NULL
than	NULL
control	NULL
cells	NULL
.	NULL

Both	NULL
fosB	NULL
and	NULL
fra-1	NULL
mRNA	NULL
accumulation	NULL
were	NULL
stimulated	NULL
by	NULL
OA	NULL
and	NULL
calyculin	NULL
A	NULL
.	NULL

5806	NULL
This	NULL
accumulation	NULL
peaked	NULL
at	NULL
30	NULL
min	NULL
.	NULL

fosB	NULL
mRNA	NULL
decreased	NULL
30	NULL
min	NULL
after	NULL
peak	NULL
time	NULL
,	NULL
whereas	NULL
fra-1	NULL
mRNA	NULL
remained	NULL
at	NULL
plateau	NULL
level	NULL
for	NULL
at	NULL
least	NULL
an	NULL
additional	NULL
90	NULL
min	NULL
.	NULL

OA	NULL
Stimulation	NULL
of	NULL
IL-18	NULL
Cytokine	NULL
Production-Unstimu-lated	NULL
monocytes	NULL
produced	NULL
little	NULL
IL-18	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

LPS	NULL
induced	NULL
major	NULL
cell-associated	NULL
IL-13	NULL
species	NULL
with	NULL
apparent	NULL
molecular	NULL
weights	NULL
of	NULL
33,000	NULL
,	NULL
31,000	NULL
,	NULL
28,500	NULL
,	NULL
18.800	NULL
,	NULL
17,500	NULL
,	NULL
17,000	NULL
,	NULL
and	NULL
15,800	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

Only	NULL
the	NULL
33,000	NULL
and	NULL
the	NULL
17,500	NULL
species	NULL
were	NULL
secreted	NULL
.	NULL

OA	NULL
stimulated	NULL
comparable	NULL
amounts	NULL
of	NULL
cellular	NULL
IL-18	NULL
as	NULL
LPS	NULL
.	NULL

However	NULL
,	NULL
there	NULL
was	NULL
slightly	NULL
more	NULL
of	NULL
the	NULL
17.5-kDa	NULL
species	NULL
in	NULL
OA-stimulated	NULL
cells	NULL
.	NULL

The	NULL
combination	NULL
of	NULL
OA	NULL
and	NULL
LPS	NULL
did	NULL
not	NULL
further	NULL
increase	NULL
the	NULL
level	NULL
of	NULL
the	NULL
individual	NULL
species	NULL
of	NULL
cell-associated	NULL
IL-1/3	NULL
.	NULL

Both	NULL
LPS	NULL
and	NULL
OA	NULL
induced	NULL
the	NULL
selective	NULL
secretion	NULL
of	NULL
the	NULL
33-	NULL
and	NULL
the	NULL
17.5-kDa	NULL
IL-18	NULL
peptides	NULL
.	NULL

This	NULL
secretion	NULL
of	NULL
both	NULL
the	NULL
precursor	NULL
and	NULL
mature	NULL
IL-1/3	NULL
species	NULL
was	NULL
not	NULL
because	NULL
of	NULL
the	NULL
loss	NULL
in	NULL
viability	NULL
of	NULL
the	NULL
treated	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
trypan	NULL
blue	NULL
exclusion	NULL
assay	NULL
,	NULL
lactate	NULL
dehydrogenase	NULL
assay	NULL
of	NULL
both	NULL
cell	NULL
lysates	NULL
and	NULL
supernatants	NULL
was	NULL
performed	NULL
to	NULL
estimate	NULL
cell	NULL
viabilities	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

The	NULL
lactate	NULL
dehydrogenase	NULL
results	NULL
showed	NULL
that	NULL
under	NULL
the	NULL
labeling	NULL
conditions	NULL
,	NULL
the	NULL
great	NULL
majority	NULL
of	NULL
lactate	NULL
dehydrogenase	NULL
activities	NULL
were	NULL
A	NULL
IL-1B	NULL
Pellet	NULL
Supernatant	NULL
kDa	NULL
1	NULL
_-2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
94	NULL
-	NULL
sys	NULL
|	NULL
67	NULL
-	NULL
43	NULL
-	NULL
=	NULL
e	NULL
--	NULL
Cen	NULL
30	NULL
~-	NULL
e	NULL
``	NULL
``	NULL
201	NULL
-	NULL
~	NULL
«	NULL
an	NULL
can	NULL
cp	NULL
144	NULL
-	NULL
K	NULL
B	NULL
IL-l	NULL
a	NULL
Pellet	NULL
Supernatant	NULL
kDa	NULL
1	NULL
-2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
&	NULL
94	NULL
-	NULL
-	NULL
mA	NULL
67	NULL
-	NULL
43	NULL
-	NULL
Thee	NULL
-	NULL
``	NULL
30	NULL
-	NULL
201	NULL
-	NULL
~	NULL
14-4	NULL
-	NULL
K	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

Stimulation	NULL
of	NULL
monocyte	NULL
IL-1	NULL
$	NULL
and	NULL
IL-1a	NULL
cytokine	NULL
production	NULL
by	NULL
OA	NULL
and	NULL
LPS	NULL
.	NULL

Monocytes	NULL
were	NULL
stimulated	NULL
in	NULL
[	NULL
*S	NULL
]	NULL
Met-containing	NULL
medium	NULL
for	NULL
6	NULL
h	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

After	NULL
stimulation	NULL
,	NULL
samples	NULL
were	NULL
divided	NULL
into	NULL
cell	NULL
pellets	NULL
(	NULL
lanes	NULL
1-4	NULL
)	NULL
and	NULL
supernatants	NULL
(	NULL
lanes	NULL
5-8	NULL
)	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
anti-IL-13	NULL
(	NULL
panel	NULL
A	NULL
)	NULL
or	NULL
anti-IL-l	NULL
«	NULL
(	NULL
panel	NULL
B	NULL
)	NULL
as	NULL
described	NULL
(	NULL
10	NULL
)	NULL
.	NULL

The	NULL
stimulants	NULL
were	NULL
:	NULL
lanes	NULL
7	NULL
and	NULL
5	NULL
,	NULL
no	NULL
stimulation	NULL
;	NULL
lanes	NULL
2	NULL
and	NULL
6	NULL
,	NULL
100	NULL
ng/ml	NULL
LPS	NULL
;	NULL
lanes	NULL
3	NULL
and	NULL
7	NULL
,	NULL
50	NULL
ng/ml	NULL
OA	NULL
;	NULL
and	NULL
lanes	NULL
4	NULL
and	NULL
8	NULL
,	NULL
100	NULL
ng/	NULL
ml	NULL
LPS	NULL
plus	NULL
50	NULL
ng/ml	NULL
OA	NULL
.	NULL

Immunoprecipitated	NULL
proteins	NULL
were	NULL
fractionated	NULL
on	NULL
a	NULL
15	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

Arrows	NULL
indicate	NULL
the	NULL
position	NULL
of	NULL
mature	NULL
IL-1	NULL
.	NULL

The	NULL
molecular	NULL
masses	NULL
of	NULL
Pharmacia	NULL
low	NULL
molecular	NULL
weight	NULL
markers	NULL
are	NULL
shown	NULL
on	NULL
the	NULL
left	NULL
.	NULL

The	NULL
gels	NULL
containing	NULL
secreted	NULL
IL-1	NULL
were	NULL
exposed	NULL
five	NULL
times	NULL
longer	NULL
than	NULL
those	NULL
containing	NULL
cell-associated	NULL
IL-1	NULL
.	NULL

One	NULL
of	NULL
three	NULL
similar	NULL
experiments	NULL
is	NULL
shown	NULL
.	NULL

Okadaic	NULL
Acid	NULL
and	NULL
Calyculin	NULL
A	NULL
Stimulation	NULL
of	NULL
IL-1	NULL
Production	NULL
20	NULL
T	NULL
I	NULL
1.5t	NULL
Cell	NULL
Sup	NULL
.	NULL

10L	NULL
&	NULL
e	NULL
0-0	NULL
C	NULL
_	NULL
|	NULL
xx	NULL
BHP	NULL
OPS	NULL
2	NULL
aa	NULL
OO	NULL
oA	NULL
5	NULL
AA	NULL
ww	NULL
L+0a	NULL
0.5|-	NULL
K	NULL
0M	NULL
0	NULL
2	NULL
4	NULL
6	NULL
Time	NULL
(	NULL
h	NULL
)	NULL
Fic	NULL
.	NULL

8	NULL
.	NULL

Time	NULL
course	NULL
of	NULL
lactate	NULL
dehydrogenase	NULL
release	NULL
into	NULL
the	NULL
supernatant	NULL
by	NULL
monocytes	NULL
stimulated	NULL
with	NULL
OA	NULL
and	NULL
LPS	NULL
.	NULL

Lactate	NULL
dehydrogenase	NULL
was	NULL
measured	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

Duplicate	NULL
samples	NULL
were	NULL
measured	NULL
for	NULL
each	NULL
time	NULL
point	NULL
.	NULL

The	NULL
mean	NULL
and	NULL
standard	NULL
deviation	NULL
(	NULL
bar	NULL
)	NULL
for	NULL
cell-associated	NULL
and	NULL
supernatant	NULL
lactate	NULL
dehydrogenase	NULL
activities	NULL
are	NULL
plotted	NULL
.	NULL

This	NULL
experiment	NULL
was	NULL
repeated	NULL
twice	NULL
.	NULL

cell-associated	NULL
.	NULL

The	NULL
supernatants	NULL
of	NULL
cell	NULL
treated	NULL
with	NULL
LPS	NULL
,	NULL
OA	NULL
,	NULL
or	NULL
LPS	NULL
plus	NULL
OA	NULL
contained	NULL
similar	NULL
lactate	NULL
dehydrogenase	NULL
levels	NULL
.	NULL

In	NULL
the	NULL
supernatants	NULL
of	NULL
unstimulated	NULL
monocytes	NULL
,	NULL
no	NULL
secreted	NULL
IL-13	NULL
was	NULL
detected	NULL
.	NULL

LPS	NULL
stimulated	NULL
the	NULL
secretion	NULL
of	NULL
more	NULL
of	NULL
the	NULL
mature	NULL
17.5-kDa	NULL
than	NULL
the	NULL
precursor	NULL
33-kDa	NULL
species	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

OA	NULL
,	NULL
despite	NULL
inducing	NULL
the	NULL
same	NULL
amount	NULL
of	NULL
mature	NULL
17.5-kDa	NULL
IL-1	NULL
,	NULL
stimulated	NULL
the	NULL
secretion	NULL
of	NULL
5-10-fold	NULL
more	NULL
of	NULL
the	NULL
33-kDa	NULL
species	NULL
than	NULL
LPS	NULL
(	NULL
compare	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
lanes	NULL
2	NULL
,	NULL
3	NULL
,	NULL
6	NULL
,	NULL
and	NULL
7	NULL
)	NULL
.	NULL

The	NULL
combination	NULL
of	NULL
OA	NULL
and	NULL
LPS	NULL
induced	NULL
comparable	NULL
secretory	NULL
levels	NULL
of	NULL
the	NULL
33-kDa	NULL
precursor	NULL
form	NULL
but	NULL
induced	NULL
much	NULL
more	NULL
mature	NULL
IL-1	NULL
$	NULL
3	NULL
than	NULL
OA	NULL
alone	NULL
.	NULL

The	NULL
major	NULL
effects	NULL
of	NULL
LPS	NULL
in	NULL
this	NULL
combination	NULL
seemed	NULL
to	NULL
be	NULL
the	NULL
stimulation	NULL
of	NULL
the	NULL
processing	NULL
of	NULL
the	NULL
precursor	NULL
IL-15	NULL
into	NULL
mature	NULL
IL-13	NULL
and	NULL
the	NULL
secretion	NULL
of	NULL
the	NULL
mature	NULL
form	NULL
.	NULL

These	NULL
effects	NULL
were	NULL
further	NULL
examined	NULL
in	NULL
an	NULL
LPS	NULL
dose-response	NULL
experiment	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Increasing	NULL
LPS	NULL
dose	NULL
from	NULL
50	NULL
to	NULL
2,500	NULL
ng/ml	NULL
had	NULL
limited	NULL
effects	NULL
on	NULL
the	NULL
production	NULL
of	NULL
cell-associated	NULL
and	NULL
secreted	NULL
IL-1	NULL
.	NULL

OA	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
LPS	NULL
induced	NULL
more	NULL
of	NULL
the	NULL
cell-associated	NULL
33-kDa	NULL
and	NULL
18.8-kDa	NULL
forms	NULL
than	NULL
LPS	NULL
alone	NULL
.	NULL

Increasing	NULL
the	NULL
LPS	NULL
concentration	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
OA	NULL
induced	NULL
only	NULL
the	NULL
increase	NULL
in	NULL
the	NULL
secreted	NULL
17.5-kDa	NULL
form	NULL
and	NULL
no	NULL
change	NULL
in	NULL
the	NULL
production	NULL
of	NULL
any	NULL
of	NULL
the	NULL
other	NULL
cell-associated	NULL
or	NULL
secreted	NULL
forms	NULL
.	NULL

These	NULL
experiments	NULL
support	NULL
the	NULL
notion	NULL
that	NULL
LPS	NULL
increases	NULL
the	NULL
processing	NULL
and	NULL
secretion	NULL
of	NULL
mature	NULL
IL-193	NULL
.	NULL

LPS	NULL
Stimulation	NULL
of	NULL
IL-18	NULL
Convertase	NULL
mRNA	NULL
Accumula-tion-To	NULL
provide	NULL
additional	NULL
support	NULL
that	NULL
LPS	NULL
stimulated	NULL
the	NULL
processing	NULL
of	NULL
precursor	NULL
to	NULL
the	NULL
mature	NULL
form	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
LPS	NULL
and	NULL
OA	NULL
on	NULL
IL-18	NULL
convertase	NULL
mRNA	NULL
accumulation	NULL
were	NULL
examined	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

Unstimulated	NULL
monocytes	NULL
expressed	NULL
primarily	NULL
the	NULL
2.5-	NULL
and	NULL
1.9-kilobase	NULL
IL-1/3	NULL
convertase	NULL
mRNA	NULL
species	NULL
and	NULL
low	NULL
levels	NULL
of	NULL
the	NULL
0.5-kilobase	NULL
species	NULL
.	NULL

LPS	NULL
stimulated	NULL
this	NULL
accumulation	NULL
about	NULL
2-fold	NULL
.	NULL

Although	NULL
OA	NULL
did	NULL
not	NULL
affect	NULL
IL-13	NULL
convertase	NULL
mRNA	NULL
accumulation	NULL
,	NULL
it	NULL
synergized	NULL
with	NULL
LPS	NULL
to	NULL
increase	NULL
this	NULL
accumulation	NULL
by	NULL
about	NULL
4-fold	NULL
.	NULL

These	NULL
Okadaic	NULL
Acid	NULL
and	NULL
Calyculin	NULL
A	NULL
Stimulation	NULL
of	NULL
IL-1	NULL
Production	NULL
LPS	NULL
Oa	NULL
-	NULL
L+OA	NULL
Col	NULL
525054	NULL
4	NULL
(	NULL
525	NULL
251mm	NULL
Convertose	NULL
288	NULL
-	NULL
yu	NULL
u	NULL
@	NULL
=	NULL
w	NULL
up	NULL
=	NULL
un	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
Fic	NULL
.	NULL

9	NULL
.	NULL

Stimulation	NULL
of	NULL
monocyte	NULL
convertase	NULL
mRNA	NULL
expression	NULL
by	NULL
LPS	NULL
and	NULL
OA	NULL
.	NULL

Monocytes	NULL
at	NULL
5	NULL
x	NULL
10°	NULL
cells/ml	NULL
(	NULL
10	NULL
x	NULL
10°	NULL
cells/sample	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
0.1-2.5	NULL
ug/ml	NULL
LPS	NULL
(	NULL
lanes	NULL
2-4	NULL
)	NULL
,	NULL
50-100	NULL
ng/ml	NULL
OA	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
,	NULL
or	NULL
0.1-2.5	NULL
ug/ml	NULL
LPS	NULL
plus	NULL
50	NULL
ng/ml	NULL
OA	NULL
(	NULL
lanes	NULL
7-9	NULL
)	NULL
for	NULL
2	NULL
h	NULL
followed	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

The	NULL
results	NULL
are	NULL
representative	NULL
of	NULL
two	NULL
similar	NULL
experiments	NULL
.	NULL

Kb	NULL
,	NULL
kilobases	NULL
.	NULL

results	NULL
suggest	NULL
that	NULL
a	NULL
mechanism	NULL
by	NULL
which	NULL
LPS	NULL
increased	NULL
mature	NULL
IL-13	NULL
production	NULL
is	NULL
increasing	NULL
IL-18	NULL
convertase	NULL
syn-thesis	NULL
.	NULL

OA	NULL
Stimulation	NULL
of	NULL
IL-1	NULL
«	NULL
Cytokine	NULL
Production-Resting	NULL
monocytes	NULL
produced	NULL
no	NULL
IL-1a	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
5	NULL
)	NULL
.	NULL

LPS	NULL
stimulated	NULL
the	NULL
production	NULL
of	NULL
a	NULL
minor	NULL
34.5-kDa	NULL
and	NULL
a	NULL
major	NULL
33-kDa	NULL
IL-1	NULL
@	NULL
cell-associated	NULL
precursor	NULL
form	NULL
and	NULL
a	NULL
17.5-kDa	NULL
mature	NULL
form	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

All	NULL
of	NULL
these	NULL
forms	NULL
were	NULL
secreted	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
Northern	NULL
blot	NULL
results	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
,	NULL
OA	NULL
alone	NULL
stimulated	NULL
little	NULL
IL-1a	NULL
«	NULL
production	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

The	NULL
combination	NULL
of	NULL
OA	NULL
and	NULL
LPS	NULL
stimulated	NULL
more	NULL
of	NULL
the	NULL
secreted	NULL
mature	NULL
17.5-kDa	NULL
form	NULL
.	NULL

Interestingly	NULL
,	NULL
a	NULL
series	NULL
of	NULL
bands	NULL
with	NULL
apparent	NULL
molecular	NULL
weights	NULL
between	NULL
47,000	NULL
and	NULL
31,000	NULL
appeared	NULL
in	NULL
both	NULL
pellets	NULL
and	NULL
supernatants	NULL
when	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
either	NULL
OA	NULL
alone	NULL
,	NULL
or	NULL
OA	NULL
with	NULL
LPS	NULL
.	NULL

Because	NULL
IL-1a	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
phosphorylated	NULL
(	NULL
38	NULL
)	NULL
,	NULL
the	NULL
obvious	NULL
explanation	NULL
for	NULL
the	NULL
appearance	NULL
of	NULL
the	NULL
slower	NULL
migrating	NULL
bands	NULL
is	NULL
that	NULL
they	NULL
are	NULL
the	NULL
phosphorylated	NULL
form	NULL
of	NULL
IL-1	NULL
@	NULL
.	NULL

This	NULL
was	NULL
tested	NULL
in	NULL
labeling	NULL
experiments	NULL
with	NULL
P	NULL
;	NULL
.	NULL

TNF	NULL
and	NULL
IL-18	NULL
were	NULL
not	NULL
labeled	NULL
by	NULL
*°P	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

All	NULL
of	NULL
the	NULL
major	NULL
S-labeled	NULL
cell-associated	NULL
IL-1a	NULL
species	NULL
were	NULL
labeled	NULL
by	NULL
*°P	NULL
,	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
mature	NULL
IL-1	NULL
«	NULL
(	NULL
Fig	NULL
.	NULL

10	NULL
,	NULL
compare	NULL
lanes	NULL
4	NULL
in	NULL
panels	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
OA	NULL
increased	NULL
the	NULL
production	NULL
of	NULL
the	NULL
33	NULL
kDa	NULL
and	NULL
higher	NULL
molecular	NULL
mass	NULL
forms	NULL
that	NULL
were	NULL
labeled	NULL
by	NULL
both	NULL
P	NULL
;	NULL
and	NULL
[	NULL
*S	NULL
]	NULL
Met	NULL
(	NULL
Fig	NULL
.	NULL

10	NULL
,	NULL
lanes	NULL
4	NULL
,	NULL
panels	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
support	NULL
the	NULL
notion	NULL
that	NULL
OA	NULL
increases	NULL
the	NULL
phosphorylation	NULL
of	NULL
IL-1	NULL
«	NULL
and	NULL
that	NULL
the	NULL
phosphorylated	NULL
forms	NULL
appear	NULL
as	NULL
slower	NULL
migrating	NULL
band	NULL
in	NULL
denaturing	NULL
polyacrylamide	NULL
gels	NULL
.	NULL

Phagocytic	NULL
and	NULL
Pinocytic	NULL
Functions	NULL
of	NULL
Monocytes	NULL
Treated	NULL
with	NULL
OA-Because	NULL
OA	NULL
was	NULL
toxic	NULL
to	NULL
monocytes	NULL
incubated	NULL
for	NULL
more	NULL
than	NULL
4	NULL
h	NULL
at	NULL
doses	NULL
higher	NULL
than	NULL
200	NULL
ng/ml	NULL
,	NULL
the	NULL
integrity	NULL
of	NULL
the	NULL
monocyte	NULL
cellular	NULL
function	NULL
represented	NULL
by	NULL
endocytic	NULL
capabilities	NULL
in	NULL
OA-containing	NULL
medium	NULL
was	NULL
examined	NULL
.	NULL

Monocytes	NULL
in	NULL
culture	NULL
tend	NULL
to	NULL
detach	NULL
from	NULL
substrates	NULL
with	NULL
incubation	NULL
time	NULL
.	NULL

Thus	NULL
,	NULL
phagocytic	NULL
and	NULL
pinocytic	NULL
functions	NULL
were	NULL
examined	NULL
over	NULL
a	NULL
2-h	NULL
drug	NULL
treatment	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Table	NULL
I	NULL
,	NULL
OA	NULL
over	NULL
a	NULL
dose	NULL
range	NULL
of	NULL
50-200	NULL
ng/m	NULL
!	NULL

either	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
LPS	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
phagocytosis	NULL
of	NULL
IgG-coated	NULL
erythrocytes	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
pinocytosis	NULL
of	NULL
horseradish	NULL
peroxidase	NULL
by	NULL
monocytes	NULL
in	NULL
OA-containing	NULL
medium	NULL
with	NULL
or	NULL
without	NULL
LPS	NULL
was	NULL
not	NULL
adversely	NULL
affected	NULL
by	NULL
the	NULL
drugs	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
OA	NULL
does	NULL
not	NULL
impair	NULL
monocyte	NULL
cellular	NULL
functions	NULL
under	NULL
the	NULL
experimental	NULL
conditions	NULL
studied	NULL
.	NULL

DISCUSSION	NULL
Ser/Thr	NULL
protein	NULL
phosphatase	NULL
inhibitors	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
exert	NULL
multiple	NULL
effects	NULL
on	NULL
various	NULL
cellular	NULL
functions	NULL
(	NULL
20-29	NULL
)	NULL
.	NULL

5807	NULL
A	NULL
32p	NULL
B	NULL
355	NULL
kDa	NULL
-	NULL
|	NULL
2	NULL
3	NULL
4	NULL
|	NULL
2	NULL
3	NULL
4	NULL
wor	NULL
we	NULL
ome	NULL
cage	NULL
94	NULL
-	NULL
s	NULL
stn	NULL
67	NULL
-	NULL
-	NULL
e	NULL
43	NULL
-	NULL
tas	NULL
e	NULL
»	NULL
-	NULL
(	NULL
4	NULL
s-	NULL
Q	NULL
``	NULL
201	NULL
-	NULL
=	NULL
|	NULL
4	NULL
A	NULL
~	NULL
*	NULL
we	NULL
,	NULL
Fig	NULL
.	NULL

10	NULL
.	NULL

Phosphorylation	NULL
of	NULL
IL-1	NULL
«	NULL
in	NULL
monocytes	NULL
stimulated	NULL
by	NULL
OA	NULL
.	NULL

Monocytes	NULL
were	NULL
labeled	NULL
with	NULL
P	NULL
;	NULL
(	NULL
panel	NULL
A	NULL
)	NULL
or	NULL
[	NULL
*S	NULL
}	NULL
)	NULL
Met	NULL
(	NULL
panel	NULL
B	NULL
)	NULL
for	NULL
6	NULL
h	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
``	NULL
and	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

In	NULL
this	NULL
experiment	NULL
,	NULL
10	NULL
x	NULL
10°	NULL
cells	NULL
were	NULL
used	NULL
for	NULL
each	NULL
sample	NULL
.	NULL

The	NULL
immunoprecipitated	NULL
cell-associated	NULL
IL-1	NULL
«	NULL
was	NULL
fractionated	NULL
on	NULL
a	NULL
10	NULL
%	NULL
acrylamide	NULL
gel	NULL
for	NULL
better	NULL
resolution	NULL
of	NULL
the	NULL
30-40-kDa	NULL
region	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
control	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
100	NULL
ng/ml	NULL
LPS	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
50	NULL
ng/	NULL
ml	NULL
OA	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
100	NULL
ng/ml	NULL
LPS	NULL
and	NULL
50	NULL
ng/ml	NULL
OA	NULL
.	NULL

One	NULL
of	NULL
two	NULL
similar	NULL
experiments	NULL
is	NULL
shown	NULL
.	NULL

The	NULL
thick	NULL
arrow	NULL
identifies	NULL
an	NULL
S-labeled	NULL
band	NULL
of	NULL
unknown	NULL
origin	NULL
.	NULL

The	NULL
thin	NULL
arrows	NULL
indicate	NULL
the	NULL
positions	NULL
of	NULL
the	NULL
precursor	NULL
and	NULL
mature	NULL
IL-l	NULL
«	NULL
.	NULL

OA	NULL
regulates	NULL
cell	NULL
cycle	NULL
progression	NULL
and	NULL
stimulates	NULL
gene	NULL
tran-scription	NULL
,	NULL
protein	NULL
secretion	NULL
,	NULL
glucose	NULL
and	NULL
ion	NULL
transport	NULL
,	NULL
and	NULL
glucose	NULL
metabolism	NULL
.	NULL

Its	NULL
regulation	NULL
of	NULL
these	NULL
processes	NULL
is	NULL
a	NULL
result	NULL
of	NULL
the	NULL
increase	NULL
in	NULL
phosphorylation	NULL
state	NULL
of	NULL
crucial	NULL
regulatory	NULL
proteins	NULL
such	NULL
as	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
,	NULL
histones	NULL
,	NULL
G	NULL
proteins	NULL
,	NULL
ion	NULL
channels	NULL
,	NULL
and	NULL
transcription	NULL
factors	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
found	NULL
that	NULL
many	NULL
of	NULL
these	NULL
processes	NULL
involved	NULL
in	NULL
the	NULL
monocyte	NULL
production	NULL
of	NULL
IL-18	NULL
and	NULL
IL-1a	NULL
«	NULL
were	NULL
affected	NULL
by	NULL
OA	NULL
or	NULL
calyculin	NULL
A.	NULL
OA	NULL
increased	NULL
the	NULL
transcription	NULL
rate	NULL
,	NULL
steady-state	NULL
mRNA	NULL
level	NULL
,	NULL
and	NULL
cytokine	NULL
production	NULL
of	NULL
IL-18	NULL
and	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
,	NULL
those	NULL
of	NULL
IL-1a	NULL
@	NULL
.	NULL

Steady-state	NULL
mRNA	NULL
level	NULL
of	NULL
IL-6	NULL
,	NULL
another	NULL
cytokine	NULL
produced	NULL
by	NULL
monocytes	NULL
,	NULL
was	NULL
not	NULL
increased	NULL
appreciably	NULL
by	NULL
OA	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
protein	NULL
phosphatase	NULL
1	NULL
and	NULL
2A	NULL
inhibitors	NULL
have	NULL
differential	NULL
effects	NULL
on	NULL
the	NULL
mRNA	NULL
accumulation	NULL
of	NULL
different	NULL
cytokines	NULL
.	NULL

Although	NULL
calyculin	NULL
A	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
comparable	NULL
to	NULL
OA	NULL
in	NULL
stimulating	NULL
monocyte	NULL
cytokine	NULL
mRNA	NULL
accumulation	NULL
at	NULL
low	NULL
concentrations	NULL
,	NULL
it	NULL
was	NULL
found	NULL
to	NULL
inhibit	NULL
LPS-stimulated	NULL
cytokine	NULL
mRNA	NULL
increase	NULL
between	NULL
30	NULL
and	NULL
100	NULL
ng/ml	NULL
(	NULL
26	NULL
)	NULL
,	NULL
whereas	NULL
OA	NULL
up	NULL
to	NULL
200	NULL
ng/ml	NULL
did	NULL
not	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

Calyculin	NULL
A	NULL
was	NULL
also	NULL
more	NULL
potent	NULL
in	NULL
stimulating	NULL
IL-18	NULL
mRNA	NULL
accumulation	NULL
in	NULL
the	NULL
myeloid	NULL
cell	NULL
line	NULL
HL-60	NULL
than	NULL
OA	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
actions	NULL
of	NULL
the	NULL
two	NULL
inhibitors	NULL
in	NULL
regulating	NULL
cytokine	NULL
mRNA	NULL
accumulation	NULL
are	NULL
not	NULL
equiva-lent	NULL
.	NULL

Because	NULL
calyculin	NULL
A	NULL
inhibits	NULL
protein	NULL
phosphatase	NULL
1	NULL
10-100-fold	NULL
better	NULL
than	NULL
OA	NULL
(	NULL
20	NULL
)	NULL
,	NULL
the	NULL
difference	NULL
in	NULL
this	NULL
stimulation	NULL
between	NULL
calyculin	NULL
A	NULL
and	NULL
OA	NULL
may	NULL
be	NULL
a	NULL
result	NULL
of	NULL
protein	NULL
phosphatase	NULL
1	NULL
inhibition	NULL
by	NULL
calyculin	NULL
A	NULL
.	NULL

Despite	NULL
these	NULL
differences	NULL
in	NULL
action	NULL
between	NULL
OA	NULL
and	NULL
calyculin	NULL
A	NULL
,	NULL
there	NULL
is	NULL
insufficient	NULL
information	NULL
to	NULL
determine	NULL
whether	NULL
protein	NULL
phosphatase	NULL
1	NULL
or	NULL
2A	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
stimulation	NULL
of	NULL
IL-13	NULL
and	NULL
IL-1a	NULL
transcription	NULL
and	NULL
cytokine	NULL
production	NULL
in	NULL
monocytes	NULL
.	NULL

OA	NULL
stimulated	NULL
and	NULL
IL-1a	NULL
transcription	NULL
rate	NULL
.	NULL

It	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
stimulate	NULL
the	NULL
activities	NULL
of	NULL
the	NULL
binding	NULL
factors	NULL
AP-1	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
and	NULL
Egr-1	NULL
(	NULL
26-29	NULL
)	NULL
.	NULL

Motifs	NULL
for	NULL
AP-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
are	NULL
present	NULL
in	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
two	NULL
IL-1	NULL
genes	NULL
.	NULL

Although	NULL
the	NULL
role	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
motifs	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
IL-1	NULL
transcription	NULL
is	NULL
poorly	NULL
understood	NULL
,	NULL
an	NULL
AP-1	NULL
binding	NULL
site	NULL
in	NULL
an	NULL
enhancer	NULL
region	NULL
located	NULL
2.9	NULL
kilobases	NULL
upstream	NULL
of	NULL
IL-1	NULL
$	NULL
transcription	NULL
start	NULL
site	NULL
has	NULL
been	NULL
implicated	NULL
to	NULL
be	NULL
important	NULL
for	NULL
phorbol	NULL
ester	NULL
induction	NULL
of	NULL
the	NULL
IL-1	NULL
gene	NULL
5808	NULL
Okadaic	NULL
Acid	NULL
and	NULL
Calyculin	NULL
A	NULL
Stimulation	NULL
of	NULL
IL-1	NULL
Production	NULL
TABLE	NULL
I	NULL
Phagocytosis	NULL
and	NULL
pinocytosis	NULL
of	NULL
monocytes	NULL
treated	NULL
with	NULL
OA	NULL
and	NULL
LPS	NULL
Monqcytes	NULL
were	NULL
plated	NULL
in	NULL
24-well	NULL
plates	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

After	NULL
preincubation	NULL
for	NULL
1	NULL
h	NULL
in	NULL
medium	NULL
containing	NULL
Fhe	NULL
indicated	NULL
drugs	NULL
,	NULL
IgG-coated	NULL
erythrocytes	NULL
or	NULL
horseradish	NULL
peroxidase	NULL
was	NULL
added	NULL
to	NULL
the	NULL
cells	NULL
.	NULL

Phagocytosis	NULL
was	NULL
expressed	NULL
as	NULL
phagocytic	NULL
index	NULL
,	NULL
the	NULL
gumber	NULL
91	NULL
``	NULL
IgG-coated	NULL
erythrocytes	NULL
ingested	NULL
by	NULL
100	NULL
monocytes	NULL
.	NULL

Horseradish	NULL
peroxidase	NULL
uptake	NULL
was	NULL
measured	NULL
in	NULL
duplicate	NULL
wells	NULL
and	NULL
normalized	NULL
against	NULL
cell	NULL
protein	NULL
as	NULL
described	NULL
(	NULL
34	NULL
)	NULL
.	NULL

The	NULL
results	NULL
are	NULL
expressed	NULL
as	NULL
ng	NULL
of	NULL
horseradish	NULL
peroxidase/mg	NULL
of	NULL
cell	NULL
protein	NULL
+	NULL
S.D	NULL
.	NULL

Each	NULL
of	NULL
these	NULL
experiments	NULL
is	NULL
representative	NULL
of	NULL
two	NULL
independent	NULL
trials	NULL
.	NULL

Phagocytosis	NULL
Pinocytosis	NULL
Treatment	NULL
[	NULL
OA	NULL
]	NULL
1	NULL
Phagocytic	NULL
index	NULL
%	NULL
control	NULL
pergzgsfsgiisgke	NULL
%	NULL
control	NULL
ng/ml	NULL
ng/mg	NULL
protein	NULL
Control	NULL
274	NULL
100	NULL
58	NULL
+	NULL
9.0	NULL
100	NULL
LPS	NULL
229	NULL
84	NULL
40	NULL
+	NULL
0.9	NULL
69	NULL
OA	NULL
50	NULL
244	NULL
89	NULL
48	NULL
+	NULL
3.8	NULL
84	NULL
100	NULL
236	NULL
86	NULL
49	NULL
+	NULL
8.2	NULL
85	NULL
200	NULL
267	NULL
94	NULL
ND®	NULL
ND	NULL
LPS	NULL
+	NULL
OA	NULL
50	NULL
230	NULL
84	NULL
46	NULL
+	NULL
3.9	NULL
80	NULL
100	NULL
241	NULL
88	NULL
68	NULL
+	NULL
14	NULL
117	NULL
200	NULL
235	NULL
86	NULL
ND	NULL
ND	NULL
*	NULL
ND	NULL
,	NULL
not	NULL
determined	NULL
.	NULL

(	NULL
35	NULL
)	NULL
.	NULL

However	NULL
,	NULL
because	NULL
of	NULL
the	NULL
complexity	NULL
of	NULL
the	NULL
regulation	NULL
of	NULL
AP-1	NULL
activity	NULL
,	NULL
it	NULL
is	NULL
unclear	NULL
how	NULL
OA	NULL
stimulates	NULL
AP-1	NULL
binding	NULL
.	NULL

AP-1	NULL
is	NULL
composed	NULL
of	NULL
dimers	NULL
of	NULL
various	NULL
fos-	NULL
and	NULL
jun-related	NULL
proteins	NULL
which	NULL
can	NULL
regulate	NULL
gene	NULL
transcription	NULL
either	NULL
positively	NULL
or	NULL
negatively	NULL
(	NULL
15	NULL
)	NULL
.	NULL

c-jun	NULL
and	NULL
junD	NULL
have	NULL
been	NULL
found	NULL
to	NULL
regulate	NULL
transcription	NULL
positively	NULL
,	NULL
whereas	NULL
jun	NULL
B	NULL
regulates	NULL
negatively	NULL
(	NULL
36	NULL
,	NULL
37	NULL
)	NULL
.	NULL

We	NULL
have	NULL
observed	NULL
the	NULL
increase	NULL
in	NULL
accumulation	NULL
of	NULL
all	NULL
three	NULL
jun-related	NULL
mRNA	NULL
in	NULL
monocytes	NULL
upon	NULL
OA	NULL
or	NULL
calyculin	NULL
A	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

How	NULL
this	NULL
increase	NULL
in	NULL
mRNA	NULL
levels	NULL
determines	NULL
the	NULL
cellular	NULL
proportion	NULL
of	NULL
different	NULL
jun-related	NULL
proteins	NULL
and	NULL
what	NULL
the	NULL
final	NULL
net	NULL
effect	NULL
these	NULL
different	NULL
dimers	NULL
have	NULL
on	NULL
IL-1	NULL
gene	NULL
transcription	NULL
remain	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

An	NULL
additional	NULL
level	NULL
of	NULL
complexity	NULL
of	NULL
binding	NULL
factor	NULL
activity	NULL
regulation	NULL
by	NULL
stimulants	NULL
such	NULL
as	NULL
OA	NULL
occurs	NULL
because	NULL
binding	NULL
activities	NULL
are	NULL
determined	NULL
by	NULL
the	NULL
phosphorylation	NULL
state	NULL
of	NULL
the	NULL
dimers	NULL
.	NULL

c-Ha-ras	NULL
and	NULL
PMA	NULL
stimulate	NULL
AP-1	NULL
binding	NULL
activity	NULL
by	NULL
increasing	NULL
and	NULL
decreasing	NULL
the	NULL
phosphorylation	NULL
state	NULL
of	NULL
two	NULL
different	NULL
sets	NULL
of	NULL
phosphorylation	NULL
sites	NULL
,	NULL
respectively	NULL
(	NULL
39	NULL
,	NULL
40	NULL
)	NULL
.	NULL

It	NULL
is	NULL
conceivable	NULL
that	NULL
OA	NULL
regulates	NULL
AP-1	NULL
activity	NULL
by	NULL
both	NULL
increasing	NULL
the	NULL
synthesis	NULL
of	NULL
and	NULL
modulating	NULL
the	NULL
phosphorylation	NULL
state	NULL
of	NULL
jun-related	NULL
proteins	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
OA	NULL
can	NULL
also	NULL
increase	NULL
AP-1	NULL
binding	NULL
by	NULL
increasing	NULL
either	NULL
the	NULL
synthesis	NULL
of	NULL
fos-related	NULL
proteins	NULL
or	NULL
by	NULL
stimulating	NULL
c-fos	NULL
phos-phorylation	NULL
,	NULL
which	NULL
also	NULL
results	NULL
in	NULL
AP-1	NULL
stimulation	NULL
(	NULL
15	NULL
)	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
that	NULL
fosB	NULL
and	NULL
fra-1	NULL
mRNA	NULL
is	NULL
increased	NULL
by	NULL
OA	NULL
and	NULL
calyculin	NULL
A	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Although	NULL
c-fos	NULL
mRNA	NULL
level	NULL
did	NULL
not	NULL
correlate	NULL
with	NULL
AP-1	NULL
activities	NULL
,	NULL
OA	NULL
may	NULL
still	NULL
increase	NULL
AP-1	NULL
binding	NULL
by	NULL
stimulating	NULL
the	NULL
phosphorylation	NULL
of	NULL
the	NULL
c-Fos	NULL
pro-tein	NULL
.	NULL

OA	NULL
can	NULL
similarly	NULL
stimulate	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
by	NULL
modulating	NULL
the	NULL
phosphorylation	NULL
state	NULL
of	NULL
I	NULL
«	NULL
B	NULL
or	NULL
NF-	NULL
«	NULL
B	NULL
sub-units	NULL
(	NULL
41	NULL
)	NULL
.	NULL

The	NULL
regulation	NULL
of	NULL
the	NULL
stability	NULL
of	NULL
IL-18	NULL
and	NULL
IL-la	NULL
mRNA	NULL
is	NULL
different	NULL
from	NULL
that	NULL
of	NULL
TNF	NULL
mRNA	NULL
,	NULL
although	NULL
all	NULL
three	NULL
mRNAs	NULL
contain	NULL
the	NULL
AUUUA	NULL
motif	NULL
shown	NULL
to	NULL
be	NULL
crucial	NULL
for	NULL
cytokine	NULL
and	NULL
oncogene	NULL
mRNA	NULL
destabilization	NULL
(	NULL
42	NULL
)	NULL
.	NULL

TNF	NULL
mRNA	NULL
is	NULL
more	NULL
stable	NULL
in	NULL
monocytes	NULL
stimulated	NULL
by	NULL
OA	NULL
than	NULL
by	NULL
LPS	NULL
(	NULL
26	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
stabilities	NULL
of	NULL
IL-18	NULL
and	NULL
IL-1	NULL
«	NULL
mRNA	NULL
were	NULL
comparable	NULL
in	NULL
cells	NULL
stimulated	NULL
by	NULL
either	NULL
agent	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
IL-1a	NULL
mRNA	NULL
was	NULL
found	NULL
to	NULL
be	NULL
slightly	NULL
more	NULL
stable	NULL
in	NULL
LPS-stimulated	NULL
cells	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
LPS	NULL
may	NULL
also	NULL
stabilize	NULL
AUUUA-containing	NULL
mRNA	NULL
by	NULL
stimulating	NULL
protein	NULL
kinase	NULL
C	NULL
,	NULL
which	NULL
stabilizes	NULL
TNF	NULL
mRNA	NULL
(	NULL
16	NULL
,	NULL
42	NULL
)	NULL
.	NULL

This	NULL
stabilization	NULL
may	NULL
also	NULL
explain	NULL
the	NULL
elevation	NULL
of	NULL
IL-1l1a	NULL
and	NULL
IL-6	NULL
mRNA	NULL
accumulation	NULL
in	NULL
LPS-stimulated	NULL
monocytes	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
,	NULL
which	NULL
exhibited	NULL
only	NULL
small	NULL
increases	NULL
in	NULL
the	NULL
transcription	NULL
rate	NULL
of	NULL
these	NULL
genes	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
mechanism	NULL
of	NULL
cytokine	NULL
mRNA	NULL
stabilization	NULL
has	NULL
not	NULL
been	NULL
elucidated	NULL
.	NULL

In	NULL
the	NULL
AUUUA-containing	NULL
oncogene	NULL
mRNA	NULL
c-fos	NULL
and	NULL
c-myc	NULL
,	NULL
multiple	NULL
domains	NULL
in	NULL
the	NULL
mRNA	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
confer	NULL
destabilization	NULL
(	NULL
43	NULL
,	NULL
44	NULL
)	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
IL-1	NULL
,	NULL
IL-1a	NULL
,	NULL
and	NULL
TNF	NULL
mRNA	NULL
contain	NULL
sequences	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
AUUUA	NULL
motifs	NULL
which	NULL
determine	NULL
their	NULL
stability	NULL
and	NULL
are	NULL
susceptible	NULL
to	NULL
different	NULL
degrees	NULL
of	NULL
regulation	NULL
by	NULL
various	NULL
agents	NULL
.	NULL

The	NULL
conversion	NULL
of	NULL
IL-la	NULL
mRNA	NULL
into	NULL
a	NULL
doublet	NULL
during	NULL
its	NULL
decay	NULL
may	NULL
be	NULL
caused	NULL
by	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
addition	NULL
or	NULL
trimming	NULL
.	NULL

Trimming	NULL
of	NULL
the	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
tail	NULL
has	NULL
been	NULL
observed	NULL
for	NULL
the	NULL
AUUUA-containing	NULL
oncogene	NULL
mRNA	NULL
c-fos	NULL
and	NULL
c-myc	NULL
(	NULL
43	NULL
,	NULL
44	NULL
)	NULL
.	NULL

OA	NULL
stimulated	NULL
IL-18	NULL
cytokine	NULL
production	NULL
differently	NULL
from	NULL
LPS	NULL
.	NULL

Although	NULL
LPS	NULL
stimulated	NULL
primarily	NULL
the	NULL
secretion	NULL
of	NULL
mature	NULL
IL-1	NULL
$	NULL
9	NULL
,	NULL
OA	NULL
stimulated	NULL
the	NULL
production	NULL
of	NULL
more	NULL
of	NULL
the	NULL
secreted	NULL
precursor	NULL
form	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
stimulating	NULL
the	NULL
translation	NULL
of	NULL
precursor	NULL
IL-18	NULL
,	NULL
LPS	NULL
may	NULL
also	NULL
stimulate	NULL
the	NULL
processing	NULL
of	NULL
the	NULL
precursor	NULL
IL-18	NULL
and	NULL
secretion	NULL
of	NULL
the	NULL
mature	NULL
form	NULL
.	NULL

This	NULL
is	NULL
supported	NULL
by	NULL
our	NULL
finding	NULL
that	NULL
there	NULL
is	NULL
less	NULL
cell-associated	NULL
mature	NULL
IL-18	NULL
and	NULL
secreted	NULL
precursor	NULL
IL-18	NULL
in	NULL
LPS-than	NULL
in	NULL
OA-stimulated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
increasing	NULL
the	NULL
LPS	NULL
concentration	NULL
while	NULL
keeping	NULL
the	NULL
OA	NULL
concentration	NULL
constant	NULL
increased	NULL
only	NULL
the	NULL
proportion	NULL
of	NULL
mature	NULL
IL-18	NULL
secreted	NULL
into	NULL
the	NULL
medium	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
for	NULL
convertase	NULL
showed	NULL
that	NULL
LPS	NULL
was	NULL
a	NULL
better	NULL
stimulant	NULL
of	NULL
the	NULL
mRNA	NULL
accumulation	NULL
of	NULL
this	NULL
protease	NULL
than	NULL
OA	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

Although	NULL
not	NULL
shown	NULL
directly	NULL
by	NULL
enzyme	NULL
assays	NULL
or	NULL
immunopre-cipitation	NULL
,	NULL
this	NULL
result	NULL
suggests	NULL
that	NULL
LPS	NULL
increases	NULL
the	NULL
synthesis	NULL
of	NULL
IL-18	NULL
convertase	NULL
.	NULL

The	NULL
preferential	NULL
secretion	NULL
of	NULL
the	NULL
IL-18	NULL
mature	NULL
form	NULL
in	NULL
LPS-containing	NULL
medium	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
lanes	NULL
6	NULL
and	NULL
8	NULL
)	NULL
may	NULL
also	NULL
suggest	NULL
that	NULL
the	NULL
mature	NULL
form	NULL
is	NULL
secreted	NULL
more	NULL
efficiently	NULL
by	NULL
monocytes	NULL
than	NULL
the	NULL
precursor	NULL
form	NULL
.	NULL

However	NULL
,	NULL
LPS	NULL
as	NULL
well	NULL
as	NULL
OA	NULL
may	NULL
directly	NULL
stimulate	NULL
the	NULL
secretory	NULL
process	NULL
in	NULL
addition	NULL
to	NULL
regulating	NULL
IL-18	NULL
#	NULL
processing	NULL
.	NULL

The	NULL
stimulation	NULL
of	NULL
IL-1a	NULL
precursor	NULL
phosphorylation	NULL
by	NULL
OA	NULL
suggests	NULL
that	NULL
under	NULL
normal	NULL
circumstances	NULL
,	NULL
IL-la	NULL
precursor	NULL
is	NULL
phosphorylated	NULL
by	NULL
kinases	NULL
and	NULL
dephosphorylated	NULL
by	NULL
protein	NULL
phosphatase	NULL
1	NULL
or	NULL
2A	NULL
.	NULL

The	NULL
favored	NULL
phosphorylation	NULL
position	NULL
is	NULL
Ser-90	NULL
,	NULL
although	NULL
minor	NULL
phosphorylation	NULL
was	NULL
also	NULL
found	NULL
at	NULL
Ser-92	NULL
and	NULL
Ser-102	NULL
(	NULL
38	NULL
)	NULL
.	NULL

None	NULL
of	NULL
the	NULL
phosphorylated	NULL
positions	NULL
is	NULL
in	NULL
the	NULL
mature	NULL
peptide	NULL
,	NULL
as	NULL
has	NULL
been	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

10	NULL
)	NULL
.	NULL

OA	NULL
may	NULL
increase	NULL
the	NULL
phosphorylation	NULL
of	NULL
all	NULL
three	NULL
favored	NULL
Ser	NULL
positions	NULL
,	NULL
although	NULL
the	NULL
phosphorylation	NULL
of	NULL
other	NULL
positions	NULL
has	NULL
not	NULL
been	NULL
ruled	NULL
out	NULL
.	NULL

Because	NULL
of	NULL
the	NULL
unique	NULL
feature	NULL
of	NULL
IL-la	NULL
processing	NULL
and	NULL
secretion	NULL
,	NULL
the	NULL
phosphorylation	NULL
of	NULL
the	NULL
precursor	NULL
Okadaic	NULL
Acid	NULL
and	NULL
Calyculin	NULL
A	NULL
Stimulation	NULL
of	NULL
IL-1	NULL
Production	NULL
protein	NULL
may	NULL
serve	NULL
some	NULL
yet	NULL
unidentified	NULL
function	NULL
in	NULL
these	NULL
cellular	NULL
processes	NULL
.	NULL

The	NULL
results	NULL
in	NULL
this	NULL
report	NULL
support	NULL
the	NULL
view	NULL
that	NULL
there	NULL
is	NULL
a	NULL
strong	NULL
phosphorylation-dephosphorylation	NULL
cycle	NULL
occurring	NULL
in	NULL
primary	NULL
cells	NULL
(	NULL
20	NULL
)	NULL
.	NULL

This	NULL
is	NULL
necessary	NULL
for	NULL
rapidly	NULL
switching	NULL
cellular	NULL
functions	NULL
between	NULL
stimulated	NULL
and	NULL
resting	NULL
states	NULL
which	NULL
involves	NULL
protein	NULL
phosphorylation	NULL
for	NULL
their	NULL
interconversion	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
monocyte	NULL
production	NULL
of	NULL
IL-18	NULL
and	NULL
IL-1a	NULL
,	NULL
protein	NULL
phosphatase	NULL
1	NULL
and	NULL
2A	NULL
may	NULL
in	NULL
addition	NULL
be	NULL
important	NULL
in	NULL
maintaining	NULL
the	NULL
resting	NULL
phosphorylation	NULL
state	NULL
of	NULL
key	NULL
proteins	NULL
involved	NULL
in	NULL
transcriptional	NULL
activation	NULL
and	NULL
protein	NULL
processing	NULL
and	NULL
secretion	NULL
.	NULL

The	NULL
elucidation	NULL
of	NULL
the	NULL
role	NULL
of	NULL
these	NULL
protein	NULL
phosphatases	NULL
in	NULL
regulating	NULL
IL-1	NULL
production	NULL
will	NULL
be	NULL
of	NULL
major	NULL
future	NULL
interest	NULL
in	NULL
the	NULL
studies	NULL
of	NULL
signal	NULL
transduction	NULL
and	NULL
the	NULL
regulation	NULL
of	NULL
cellular	NULL
functions	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Dr.	NULL
Shu	NULL
Man	NULL
Fu	NULL
for	NULL
kind	NULL
support	NULL
and	NULL
advice	NULL
;	NULL
Jackie	NULL
Moore	NULL
for	NULL
assistance	NULL
in	NULL
manuscript	NULL
preparation	NULL
;	NULL
Christian	NULL
Gervin	NULL
for	NULL
technical	NULL
assistance	NULL
;	NULL
Dr.	NULL
R.	NULL
Chizzonite	NULL
for	NULL
donating	NULL
the	NULL
anti-IL-1	NULL
antibodies	NULL
;	NULL
and	NULL
Drs	NULL
.	NULL

B.	NULL
Beutler	NULL
,	NULL
R.	NULL
Bravo	NULL
,	NULL
D.	NULL
Caput	NULL
,	NULL
D.	NULL
P.	NULL
Cerretti	NULL
,	NULL
D.	NULL
Cosman	NULL
,	NULL
T.	NULL
Curran	NULL
,	NULL
M.	NULL
Kirschner	NULL
,	NULL
and	NULL
P.	NULL
Seghal	NULL
for	NULL
providing	NULL
the	NULL
cDNA	NULL
probes	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Dinarello	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Blood	NULL
77	NULL
,	NULL
1627-1652	NULL
2	NULL
.	NULL

Cerretti	NULL
,	NULL
D.	NULL
P.	NULL
,	NULL
Kozlosky	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Mosley	NULL
,	NULL
B.	NULL
,	NULL
Nelson	NULL
,	NULL
N.	NULL
,	NULL
van	NULL
Ness	NULL
,	NULL
K.	NULL
,	NULL
Greenstreet	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
March	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Kronheim	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Druck	NULL
,	NULL
T.	NULL
,	NULL
Cannizzaro	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Huebner	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Black	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Science	NULL
256	NULL
,	NULL
97-100	NULL
3	NULL
.	NULL

Thornberry	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
Bull	NULL
,	NULL
H.	NULL
G.	NULL
,	NULL
Calacay	NULL
,	NULL
K.	NULL
T.	NULL
,	NULL
Chapman	NULL
,	NULL
K.	NULL
T.	NULL
,	NULL
Howard	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
Kostura	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Miller	NULL
,	NULL
D.	NULL
K.	NULL
,	NULL
Molineaux	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Weidner	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Aunins	NULL
,	NULL
J.	NULL
,	NULL
Elliston	NULL
,	NULL
K.	NULL
O.	NULL
,	NULL
Ayala	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Casano	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
Chin	NULL
,	NULL
J.	NULL
,	NULL
Ding	NULL
,	NULL
G.	NULL
J.	NULL
,	NULL
Egger	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Gaffney	NULL
,	NULL
E.	NULL
P.	NULL
,	NULL
Limjuco	NULL
,	NULL
G.	NULL
,	NULL
Paylha	NULL
,	NULL
0	NULL
.	NULL

C.	NULL
,	NULL
Raju	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Rolando	NULL
,	NULL
A	NULL
,	NULL
M.	NULL
,	NULL
Salley	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Yamin	NULL
,	NULL
T.-T.	NULL
,	NULL
Lee	NULL
,	NULL
T.	NULL
D.	NULL
,	NULL
Shively	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
MacCross	NULL
,	NULL
M.	NULL
,	NULL
Mumford	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Schmidt	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Tocci	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Nature	NULL
856	NULL
,	NULL
768-774	NULL
4	NULL
.	NULL

Rubaégellé	NULL
,	NULL
3	NULL
``	NULL
Cozzolino	NULL
,	NULL
F.	NULL
,	NULL
Talio	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Sitia	NULL
,	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

9	NULL
,	NULL
1503-151	NULL
5	NULL
.	NULL

Suttles	NULL
,	NULL
J.	NULL
,	NULL
Giri	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
and	NULL
Mizel	NULL
,	NULL
S.	NULL
B	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

144	NULL
,	NULL
175-182	NULL
6	NULL
.	NULL

Perregaux	NULL
,	NULL
D.	NULL
,	NULL
Barberia	NULL
,	NULL
J.	NULL
,	NULL
Lanzetti	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Geoghegan	NULL
,	NULL
K.	NULL
F.	NULL
,	NULL
Carty	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
and	NULL
Gabel	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

149	NULL
,	NULL
1294-1303	NULL
7	NULL
.	NULL

Bagkogche	NULL
,	NULL
O.	NULL
,	NULL
Moreau	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
and	NULL
Lachman	NULL
,	NULL
L.	NULL
B	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

148	NULL
,	NULL
4-91	NULL
8	NULL
.	NULL

Beuscher	NULL
,	NULL
H.	NULL
U.	NULL
,	NULL
Gunther	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Rollinghoff	NULL
,	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

144	NULL
,	NULL
2179-2183	NULL
9	NULL
.	NULL

Hogquist	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
Unanue	NULL
,	NULL
E.	NULL
R.	NULL
,	NULL
and	NULL
Chaplin	NULL
,	NULL
D.	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

147	NULL
,	NULL
2181-2186	NULL
10	NULL
.	NULL

Sung	NULL
,	NULL
S.-s.	NULL
J.	NULL
,	NULL
and	NULL
Walters	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

88	NULL
,	NULL
1915-1923	NULL
5809	NULL
11	NULL
.	NULL

Tannenbaum	NULL
,	NULL
C.	NULL
S.	NULL
,	NULL
and	NULL
Hamilton	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

142	NULL
,	NULL
1274-	NULL
1280	NULL
12	NULL
.	NULL

Kern	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Lamb	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Reed	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Daniele	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
and	NULL
Nowell	NULL
,	NULL
P.	NULL
C.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

81	NULL
,	NULL
287-244	NULL
13	NULL
.	NULL

Shirakawa	NULL
,	NULL
F.	NULL
,	NULL
Chedid	NULL
,	NULL
M.	NULL
,	NULL
Suttles	NULL
,	NULL
J.	NULL
,	NULL
Pollok	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Mizel	NULL
,	NULL
S.	NULL
B	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
959-964	NULL
14	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
Valge-Archer	NULL
,	NULL
V.	NULL
E.	NULL
,	NULL
Sinsky	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
and	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175	NULL
,	NULL
853-862	NULL
.	NULL

15	NULL
.	NULL

Ransone	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
and	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

6	NULL
,	NULL
539-557	NULL
16	NULL
.	NULL

Haas	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Riethmuller	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Ziegler-Heitbrock	NULL
,	NULL
H.	NULL
W.	NULL
L.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
9563-9567	NULL
17	NULL
.	NULL

Furutani	NULL
,	NULL
Y.	NULL
,	NULL
Notake	NULL
,	NULL
M.	NULL
,	NULL
Fukui	NULL
,	NULL
T.	NULL
,	NULL
Ohue	NULL
,	NULL
M.	NULL
,	NULL
Nomura	NULL
,	NULL
H.	NULL
,	NULL
Yamada	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Nakamura	NULL
,	NULL
S.	NULL
(	NULL
1986	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

14	NULL
,	NULL
3167-3179	NULL
18	NULL
.	NULL

Clark	NULL
,	NULL
B.	NULL
D.	NULL
,	NULL
Collins	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
Gandy	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
Webb	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
and	NULL
Auron	NULL
,	NULL
P.	NULL
E.	NULL
(	NULL
1986	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

14	NULL
,	NULL
7897-7914	NULL
19	NULL
.	NULL

Berridge	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

56	NULL
,	NULL
159-198	NULL
.	NULL

20	NULL
.	NULL

Cohen	NULL
,	NULL
P.	NULL
,	NULL
Holmes	NULL
,	NULL
C.	NULL
F.	NULL
B.	NULL
,	NULL
and	NULL
Tsukitani	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

15	NULL
,	NULL
98-102	NULL
21	NULL
.	NULL

Schonthal	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
New	NULL
Biol	NULL
.	NULL

4	NULL
,	NULL
16-21	NULL
22	NULL
.	NULL

Abdul-Ghani	NULL
,	NULL
M.	NULL
,	NULL
Kravitz	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Meiri	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Rahamimoff	NULL
,	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
1803-1807	NULL
23	NULL
.	NULL

Miyasaka	NULL
,	NULL
T.	NULL
,	NULL
Miyasaka	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Saltiel	NULL
,	NULL
A.	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

168	NULL
,	NULL
1237-1243	NULL
24	NULL
.	NULL

Nagamine	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Ziegler	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
117-122	NULL
25	NULL
.	NULL

Lund	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
and	NULL
Dano	NULL
,	NULL
K.	NULL
(	NULL
1992	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

298	NULL
,	NULL
177-181	NULL
26	NULL
.	NULL

Sugg	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Walters	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Fu	NULL
,	NULL
S.	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

176	NULL
,	NULL
897~	NULL
OL	NULL
27	NULL
.	NULL

Tlgzggéxin	NULL
,	NULL
C.	NULL
,	NULL
Kim	NULL
,	NULL
S.-J	NULL
.	NULL

,	NULL
and	NULL
Kehrl	NULL
,	NULL
J.	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
9363~	NULL
28	NULL
.	NULL

Thevenin	NULL
,	NULL
C.	NULL
,	NULL
Kim	NULL
,	NULL
S.-J	NULL
.	NULL

,	NULL
Rieckman	NULL
,	NULL
P.	NULL
,	NULL
Fujiki	NULL
,	NULL
H.	NULL
,	NULL
Norcross	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Sporn	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Fauci	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
and	NULL
Kehrl	NULL
,	NULL
J.	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
New	NULL
Biol	NULL
.	NULL

2	NULL
,	NULL
793-800	NULL
29	NULL
.	NULL

Cao	NULL
,	NULL
X.	NULL
,	NULL
Mahendran	NULL
,	NULL
R.	NULL
,	NULL
Guy	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
and	NULL
Tan	NULL
,	NULL
Y.	NULL
H.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
12991-12997	NULL
30	NULL
.	NULL

Sung	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Walters	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Hudson	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Gimble	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

147	NULL
,	NULL
2047-2054	NULL
31	NULL
.	NULL

Sung	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Bjorndahl	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Wang	NULL
,	NULL
C.	NULL
Y.	NULL
,	NULL
Kao	NULL
,	NULL
H.	NULL
T.	NULL
,	NULL
and	NULL
Fu	NULL
,	NULL
S.	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

167	NULL
,	NULL
937-953	NULL
32	NULL
.	NULL

Sambrook	NULL
,	NULL
J.	NULL
,	NULL
Fritsch	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
,	NULL
2nd	NULL
Ed	NULL
.	NULL

,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
33	NULL
.	NULL

Sung	NULL
,	NULL
S.-s.	NULL
J	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

135	NULL
,	NULL
1981-1986	NULL
34	NULL
.	NULL

Suilg,6	NULL
Sés	NULL
.	NULL

g	NULL
,	NULL
Nelson	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
and	NULL
Silverstein	NULL
,	NULL
S.	NULL
C.	NULL
(	NULL
1983	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
.	NULL

Physiol	NULL
.	NULL

,	NULL
21-25	NULL
35	NULL
.	NULL

Bensi	NULL
,	NULL
G.	NULL
,	NULL
Mora	NULL
,	NULL
M.	NULL
,	NULL
Raugei	NULL
,	NULL
G.	NULL
,	NULL
Buonamassa	NULL
,	NULL
D.	NULL
T.	NULL
,	NULL
Rossini	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Melli	NULL
,	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
Growth	NULL
Diff	NULL
.	NULL

1	NULL
,	NULL
491-497	NULL
36	NULL
.	NULL

Chiu	NULL
,	NULL
R.	NULL
,	NULL
Angel	NULL
,	NULL
P	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
59	NULL
,	NULL
979-986	NULL
37	NULL
.	NULL

Schutte	NULL
,	NULL
J.	NULL
,	NULL
Viallet	NULL
,	NULL
J.	NULL
,	NULL
Nau	NULL
,	NULL
M.	NULL
,	NULL
Segal	NULL
,	NULL
S.	NULL
,	NULL
Fedorko	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Minna	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Cell	NULL
59	NULL
,	NULL
987-997	NULL
38	NULL
.	NULL

Beuscher	NULL
,	NULL
H.	NULL
U.	NULL
,	NULL
Nickells	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
and	NULL
Colten	NULL
,	NULL
H.	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Bio	NULL
!	NULL

Chem	NULL
.	NULL

263	NULL
,	NULL
4023-4028	NULL
39	NULL
.	NULL

Binetruy	NULL
,	NULL
B.	NULL
,	NULL
Smeal	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
Nature	NULL
351	NULL
,	NULL
122-127	NULL
40	NULL
.	NULL

Boyle	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Smeal	NULL
,	NULL
T.	NULL
,	NULL
Defize	NULL
,	NULL
L.	NULL
H.	NULL
K.	NULL
,	NULL
Angel	NULL
,	NULL
P.	NULL
,	NULL
Woodgett	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Karin	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Hunter	NULL
,	NULL
T.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
64	NULL
,	NULL
573-584	NULL
41	NULL
.	NULL

Link	NULL
,	NULL
E.	NULL
,	NULL
Kerr	NULL
,	NULL
L.	NULL
D.	NULL
,	NULL
Schreck	NULL
,	NULL
R.	NULL
,	NULL
Zabel	NULL
,	NULL
U.	NULL
,	NULL
Verma	NULL
,	NULL
I.	NULL
,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
,	NULL
267	NULL
,	NULL
239-246	NULL
42	NULL
.	NULL

Hentze	NULL
,	NULL
M.	NULL
W.	NULL
(	NULL
1991	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1090	NULL
,	NULL
281-292	NULL
43	NULL
.	NULL

Laird-Offringa	NULL
,	NULL
I	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
BioEssays	NULL
14	NULL
,	NULL
119-124	NULL
44	NULL
.	NULL

8115311	NULL
,	NULL
155913	NULL
,	NULL
Belasco	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
and	NULL
Greenberg	NULL
,	NULL
M.	NULL
E.	NULL
(	NULL
1991	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

5	NULL
,	NULL

